The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE), smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION.
Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. (From Enzyme Nomenclature, 1992) EC 2.1.3.2.
One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4.
An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.
An enzyme that catalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. EC 4.3.1.1.
A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.
Cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GAMMA-AMINOBUTYRIC ACID and glycine receptors are the most common receptors for fast inhibition.
The methyl homolog of parathion. An effective, but highly toxic, organothiophosphate insecticide and cholinesterase inhibitor.
Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure.
An aspartate aminotransferase found in MITOCHONDRIA.
The rate dynamics in chemical or physical systems.
A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
The monoanhydride of carbamic acid with PHOSPHORIC ACID. It is an important intermediate metabolite and is synthesized enzymatically by CARBAMYL-PHOSPHATE SYNTHASE (AMMONIA) and CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING).
An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.
An enzyme that, in the course of pyrimidine biosynthesis, catalyzes ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3.
A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Cytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety.
A hydrocarbon used as an industrial solvent. It has been used as an aerosal propellent, as a refrigerant and as a local anesthetic. (From Martindale, The Extra Pharmacopoeia, 31st ed, p1403)
This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
An enzyme that catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. EC 1.1.1.3.
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.
A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.
Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).
Derivatives of SUCCINIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,4-carboxy terminated aliphatic structure.
Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed)
An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.
An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.
A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
The 4-aminomethyl form of VITAMIN B 6. During transamination of amino acids, PYRIDOXAL PHOSPHATE is transiently converted into pyridoxamine phosphate.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
A family of compounds containing an oxo group with the general structure of 1,5-pentanedioic acid. (From Lehninger, Principles of Biochemistry, 1982, p442)
Derivatives of OXALOACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include a 2-keto-1,4-carboxy aliphatic structure.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.

Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. (1/6275)

In a slice preparation of rat visual cortex, we discovered that paired-pulse stimulation (PPS) elicits a form of homosynaptic long-term depression (LTD) in the superficial layers when carbachol (CCh) or norepinephrine (NE) is applied concurrently. PPS by itself, or CCh and NE in the absence of synaptic stimulation, produced no lasting change. The LTD induced by PPS in the presence of NE or CCh is of comparable magnitude with that obtained with prolonged low-frequency stimulation (LFS) but requires far fewer stimulation pulses (40 vs 900). The cholinergic facilitation of LTD was blocked by atropine and pirenzepine, suggesting involvement of M1 receptors. The noradrenergic facilitation of LTD was blocked by urapidil and was mimicked by methoxamine, suggesting involvement of alpha1 receptors. beta receptor agonists and antagonists were without effect. Induction of LTD by PPS was inhibited by NMDA receptor blockers (completely in the case of NE; partially in the case of CCh), suggesting that one action of the modulators is to control the gain of NMDA receptor-dependent homosynaptic LTD in visual cortex. We propose that this is a mechanism by which cholinergic and noradrenergic inputs to the neocortex modulate naturally occurring receptive field plasticity.  (+info)

Plasticity of first-order sensory synapses: interactions between homosynaptic long-term potentiation and heterosynaptically evoked dopaminergic potentiation. (2/6275)

Persistent potentiations of the chemical and electrotonic components of the eighth nerve (NVIII) EPSP recorded in vivo in the goldfish reticulospinal neuron, the Mauthner cell, can be evoked by afferent tetanization or local dendritic application of an endogenous transmitter, dopamine (3-hydroxytyramine). These modifications are attributable to the activation of distinct intracellular kinase cascades. Although dopamine-evoked potentiation (DEP) is mediated by the cAMP-dependent protein kinase (PKA), tetanization most likely activates a Ca2+-dependent protein kinase via an increased intracellular Ca2+ concentration. We present evidence that the eighth nerve tetanus that induces LTP does not act by triggering dopamine release, because it is evoked in the presence of a broad spectrum of dopamine antagonists. To test for interactions between these pathways, we applied the potentiating paradigms sequentially. When dopamine was applied first, tetanization produced additional potentiation of the mixed synaptic response, but when the sequence was reversed, DEP was occluded, indicating that the synapses potentiated by the two procedures belong to the same or overlapping populations. Experiments were conducted to determine interactions between the underlying regulatory mechanisms and the level of their convergence. Inhibiting PKA does not impede tetanus-induced LTP, and chelating postsynaptic Ca2+ with BAPTA does not block DEP, indicating that the initial steps of the induction processes are independent. Pharmacological and voltage-clamp analyses indicate that the two pathways converge on functional AMPA/kainate receptors for the chemically mediated EPSP and gap junctions for the electrotonic component or at intermediaries common to both pathways. A cellular model incorporating these interactions is proposed on the basis of differential modulation of synaptic responses via receptor-protein phosphorylation.  (+info)

Low resting potential and postnatal upregulation of NMDA receptors may cause Cajal-Retzius cell death. (3/6275)

Using in situ patch-clamp techniques in rat telencephalic slices, we have followed resting potential (RP) properties and the functional expression of NMDA receptors in neocortical Cajal-Retzius (CR) cells from embryonic day 18 to postnatal day 13, the time around which these cells normally disappear. We find that throughout their lives CR cells have a relatively depolarized RP (approximately -50 mV), which can be made more hyperpolarized (approximately -70 mV) by stimulation of the Na/K pump with intracellular ATP. The NMDA receptors of CR cells are subjected to intense postnatal upregulation, but their similar properties (EC50, Hill number, sensitivity to antagonists, conductance, and kinetics) throughout development suggest that their subunit composition remains relatively homogeneous. The low RP of CR cells is within a range that allows for the relief of NMDA channels from Mg2+ blockade. Our findings are consistent with the hypothesis that CR cells may degenerate and die subsequent to uncontrolled overload of intracellular Ca2+ via NMDA receptor activation by ambient glutamate. In support of this hypothesis we have obtained evidence showing the protection of CR cells via in vivo blockade of NMDA receptors with dizocilpine.  (+info)

Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. (4/6275)

Murine cortical cultures containing both neurons and glia (days in vitro 13-15) were exposed to periods of oxygen-glucose deprivation (5-30 min) too brief to induce neuronal death. Cultures "preconditioned" by sublethal oxygen-glucose deprivation exhibited 30-50% less neuronal death than controls when exposed to a 45-55 min period of oxygen-glucose deprivation 24 hr later. This preconditioning-induced neuroprotection was specific in that neuronal death induced by exposure to excitotoxins or to staurosporine was not attenuated. Neuroprotection was lost if the time between the preconditioning and severe insult were decreased to 7 hr or increased to 72 hr and was blocked if the NMDA antagonist 100 microM 3-((D)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid was applied during the preconditioning insult. This was true even if the duration of preconditioning was increased as far as possible (while still remaining sublethal). A similar preconditioning effect was also produced by sublethal exposure to high K+, glutamate, or NMDA but not to kainate or trans-1-aminocyclopentane-1, 3-dicarboxylic acid.  (+info)

Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines. (5/6275)

We have used confocal microscopy to monitor synaptically evoked Ca2+ transients in the dendritic spines of hippocampal pyramidal cells. Individual spines respond to single afferent stimuli (<0.1 Hz) with Ca2+ transients or failures, reflecting the probability of transmitter release at the activated synapse. Both AMPA and NMDA glutamate receptor antagonists block the synaptically evoked Ca2+ transients; the block by AMPA antagonists is relieved by low Mg2+. The Ca2+ transients are mainly due to the release of calcium from internal stores, since they are abolished by antagonists of calcium-induced calcium release (CICR); CICR antagonists, however, do not depress spine Ca2+ transients generated by backpropagating action potentials. These results have implications for synaptic plasticity, since they show that synaptic stimulation can activate NMDA receptors, evoking substantial Ca2+ release from the internal stores in spines without inducing long-term potentiation (LTP) or depression (LTD).  (+info)

Changes in protein tyrosine phosphorylation in the rat brain after cerebral ischemia in a model of ischemic tolerance. (6/6275)

A brief period of sublethal cerebral ischemia, followed by several days of recovery, renders the brain resistant to a subsequent lethal ischemic insult, a phenomenon termed ischemic preconditioning or tolerance. Ischemic tolerance was established in the rat two-vessel occlusion model of ischemia, induced by occlusion of both carotid arteries in combination with hypotension. Ischemic preconditioning (3 minutes) provided maximal neuroprotection when induced 2 days prior to a lethal ischemic insult of 9-minute duration. Neuroprotection persisted for at least 8 weeks. Since neurotransmission has been implicated in ischemic cell death, the effect of ischemic preconditioning on tyrosine phosphorylation of proteins and on the levels of glutamate receptor subunits in hippocampus and neocortex was studied. Regional levels of tyrosine phosphorylation of proteins in general and the N-methyl-D-aspartate receptor subunit NR2 in particular are markedly enhanced after ischemia in nonconditioned brains, in both the synaptosomal fraction and the whole-tissue homogenate of rat neocortex and hippocampus, but recover to control levels only in the preconditioned brain. Ischemic preconditioning selectively induces a decrease in the levels of the NR2A and NR2B subunits and a modest decrease in the levels of NR1 subunit proteins in the synaptosomal fraction of the neocortex but not hippocampus after the second lethal ischemia. It was concluded that ischemic preconditioning prevents a persistent change in cell signaling as evidenced by the tyrosine phosphorylation of proteins after the second lethal ischemic insult, which may abrogate the activation of detrimental cellular processes leading to cell death.  (+info)

Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. (7/6275)

The role of the possible retrograde messenger nitric oxide (NO) in the induction of long-term potentiation (LTP) was studied in supragranular layers of somatosensory cortical slices obtained from adult mice. High-frequency stimulation produced a slowly rising, long-lasting (50 min) and significant (P < 0.001) increase in the extracellular synaptic response by 23%. The induction of LTP was independent from activation of N-methyl-D-aspartate (NMDA) receptors, but prevented by bath application of NG-nitro-L-arginine methyl ester (L-NAME), indicating that one or several of the different NO synthases (NOS) produced NO within the postsynaptic neuron. No LTP could be induced in knockout mice lacking the endothelial NOS (eNOS) isoform. These data suggest that eNOS is involved in an NMDA receptor-independent form of LTP in the rodent cerebral cortex.  (+info)

17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. (8/6275)

Gonadal steroid hormones influence CNS functioning through a variety of different mechanisms. To test the hypothesis that estrogen modulates synaptic plasticity in the hippocampus, in vitro hippocampal slices from 2-mo-old Sprague-Dawley male rats were used to determine the effect of 17beta-estradiol on both N-methyl-D-aspartate (NMDA) receptor-mediated excitatory postsynaptic potentials (EPSPs) through intracellular recordings and long-term potentiation (LTP) through extracellular recordings. Intracellular EPSPs and extracellular field EPSPs (fEPSPs) were recorded from CA1 pyramidal cells by stimulating Schaffer collateral fibers. In intracellular experiments, slices were perfused with medium containing bicuculline (5 microM) and low Mg2+ (0.1 mM) to enhance the NMDA receptor-mediated currents and 6, 7-dinitroquinoxaline-2,3-dione (DNQX) (10 microM) to block the alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprianate (AMPA) receptor-mediated component. The effects of 17beta-estradiol on NMDA receptor-mediated activity were excitatory; concentrations >10 nM induced seizure activity, and lower concentrations (1 nM) markedly increased the amplitude of NMDA-mediated EPSPs (both the first and second responses increased during paired pulse stimulation by 180 and 197%, respectively). In extracellular experiments, slices perfused with 17beta-estradiol (100 pM) exhibited a pronounced, persisting, and significant enhancement of LTP of both the fEPSP slope (192%) and fEPSP amplitude (177%) compared with control slices (fEPSP slope = 155%; fEPSP amplitude = 156%) 30 min after high-frequency stimulation. These data demonstrate that estrogen enhances NMDA receptor-mediated currents and promotes an enhancement of LTP magnitude.  (+info)

Physiological activation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors has been proposed to play a key role in both neuronal cell function and dysfunction. In the present study, we used selective NMDA receptor antagonists to investigate the involvement of NR2A and NR2B subunits in the modulatory effect of basal NMDA receptor activity on the phosphorylation of Tau proteins. We observed, in acute hippocampal slice preparations, that blockade of NR2A-containing NMDA receptors by the NR2A antagonist NVP-AAM077 provoked the hyperphosphorylation of a residue located in the proline-rich domain of Tau (i.e., Ser199). This effect seemed to be Ser199 specific as there was no increase in phosphorylation at Ser262 and Ser409 residues located in the microtubule-binding and C-terminal domains of Tau proteins, respectively. From a mechanistic perspective, our study revealed that blockade of NR2A-containing receptors influences Tau phosphorylation probably by increasing calcium influx into neurons,
Expressions of N-methyl-D-aspartate receptors NR2A and NR2B subunit proteins in normal and sulfite-oxidase deficient rats hippocampus: effect of exogenous sulf
Pharmacological, genetic and expression studies implicate N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia (SCZ). Similarly, several lines of evidence suggest that autism spectrum disorders (ASD) could be due to an imbalance between excitatory and inhibitory neurotransmission. As part of a project aimed at exploring rare and/or de novo mutations in neurodevelopmental disorders, we have sequenced the seven genes encoding for NMDA receptor subunits (NMDARs) in a large cohort of individuals affected with SCZ or ASD (n=429 and 428, respectively), parents of these subjects and controls (n=568). Here, we identified two de novo mutations in patients with sporadic SCZ in GRIN2A and one de novo mutation in GRIN2B in a patient with ASD. Truncating mutations in GRIN2C, GRIN3A and GRIN3B were identified in both subjects and controls, but no truncating mutations were found in the GRIN1, GRIN2A, GRIN2B and GRIN2D genes, both in patients and controls, suggesting that these subunits are critical for
To identify the protein kinases regulating synaptic NMDA receptors, as well as the conditions favoring enhancement of NMDA receptor-mediated excitatory postsynaptic currents (EPSCs) by phosphorylation, we studied the effects of kinase activation and inhibition in hippocampal neurons. Inhibition of c …
TY - JOUR. T1 - Pharmacology of ACEA-1416. T2 - A potent systemically active NMDA receptor glycine site antagonist. AU - Ilyin, Victor I.. AU - Whittemore, Edward R.. AU - Tran, Minhtam. AU - Shen, Ke-Zhong. AU - Cai, Sui Xiong. AU - Kher, Sunil M.. AU - Keana, John F W. AU - Weber, Eckard. AU - Woodward, Richard M.. PY - 1996/8/29. Y1 - 1996/8/29. N2 - Excitatory amino acid receptor antagonists show potential for the treatment of ischemic stroke and head trauma. In search of novel antagonists, a series of alkyl- and alkoxyl-substituted 1,4-dihydro-2,3-quinoxalinediones were synthesized and assayed for inhibition of glutamate receptors. We report on the pharmacological characterization of one such compound, 7-chloro-6-methyl-5-nitro-1,4-dihydro-2,3-quinoxalinedione (ACEA-1416). Electrophysiological assays showed that ACEA-1416 is a potent antagonist of rat brain NMDA receptors expressed in Xenopus oocytes, and NMDA receptors expressed by cultured rat cortical neurons. Antagonism is via ...
Long-term potentiation of NMDA-receptor-mediated synaptic transmission (NMDAR-LTP) is a little-understood form of plasticity. In the present study, we investigated whether NMDAR-LTP in the dentate gyrus involves recruitment of extrasynaptic NMDARs, because NMDARs are expressed both synaptically and extrasynaptically with evidence for subtype differences at different locations. We show that before induction of NMDAR-LTP, pharmacological inhibition of glutamate transporters resulted in glutamate spillover from the synapse and activation of extrasynaptic NMDARs. After the induction of NMDAR-LTP, such activation of extrasynaptic NMDARs was absent. Activation of extrasynaptic NMDARs after glutamate uptake inhibition also occurred when synaptic NMDARs were inhibited with MK801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine maleate], and this extrasynaptically mediated NMDAR-EPSC was strongly reduced by prior induction of NMDAR-LTP. The extrasynaptic NMDARs were shown to be ...
2In slices, the potencies of the weakly (or non-) transported analogues, N-methyl-D-aspartate (NMDA) and kainate (KA) (EC50 = 40 μM each) were higher than those of the transported amino acids, D- and L-aspartate (EC50 = 250 μM and 300 μM) and D- and L-glutamate (EC50 = 540 μM and 480 μM). Quisqualate (up to 300 μM) failed to increase cyclic GMP levels significantly. The sensitivity of agonist responses to the NMDA receptor antagonist, DL-2-amino-5-phosphonovalerate (APV), was in the order NMDA , L-aspartate , L-glutamate, KA ...
N-Methyl-d-aspartate receptors (NMDAR) are involved in the regulation of alcohol drinking, but the contribution of NMDAR subunits located on specific neuronal populations remains incompletely understood. The current study examined the role of GluN2B-containing NMDARs expressed on cortical principal neurons and cortical interneurons in mouse ethanol drinking. Consumption of escalating concentrations of ethanol was measured in mice with GluN2B gene deletion in either cortical principal neurons (GluN2B(CxNULL)) or interneurons (GluN2B(InterNULL)), using a two-bottle choice paradigm. Results showed that GluN2B(InterNULL), but not GluN2B(CxNULL), mice consumed significantly less ethanol, at relatively high concentrations, than non-mutant controls. In a second paradigm in which mice were offered a 15% ethanol concentration, without escalation, GluN2B(CxNULL) mice were again no different from controls. These findings provide novel evidence for a contribution of interneuronal GluN2B-containing NMDARs in ...
Toxicol Lett. 2011 Sep 10;205(3):336-40. Epub 2011 Jun 24. Chen HH, Lin YR, Chan MH. Source Institute of Pharmacology and Toxicology, Tzu Chi University, 701, Sec. 3, Chung Yang Rd., Hualien 97004, Taiwan. Abstract Toluene, an industrial organic solvent, is voluntarily inhaled as drug of abuse. Because inhibition of N-methyl-d-aspartate (NMDA) receptors is one of…
Background Proof from both animal and human studies clearly supports the renal beneficial effects of empagliflozin (emp), a sodium glucose co-transporter 2 (SGLT2) inhibitor, but the mechanism in which it exerts its effect is not well understood. increased expression of Collagen IV, Fibronectin, transforming growth factor-beta1 (TGF-1). However, emp treatment remarkably decreased expression of TGF-1, accumulation of extracellular matrix proteins (Fibronectin, Collagen IV), as well as (phosphorylated-smad3) P-smad3. HG increased SGLT2 protein expression compared to normal glucose (NG) Bivalirudin Trifluoroacetate while emp significantly decreased SGLT2 expression. Furthermore, emp decreased high glucose-induced alpha-smooth muscle actin (-SMA) expression and reversed epithelial marker (E-catherin) suppression induced by high glucose. In addition, emp treatment for 72 h increased expression of HIF-1 protein (95% CI: -0.5918 to C0.002338, at 100nM, P 0.05, 95% CI C0.6631 to C0.07367 at 500nM, P ...
The activation of the N-methyl-D-aspartate receptor (NMDAR) is critical for the induction of synaptic plasticity in the hippocampus. Aging can alter glutamatergic synaptic transmission in the hippocampus, and cognitive impairments in aged animals are accompanied by reduced NMDARmediated plasticity at Schaffer collateral-CA1 synapses. However, the specific contribution of NMDAR subunits to NMDAR-mediated synaptic responses in aged tissue has not yet been fully understood. The main purpose of present study was to examine whether there is an impact of aging on NMDAR subunit expression and whether synaptic plasticity may depend on NMDAR subunit composition in the aged hippocampus ...
In this study, N-methyl-D-aspartate (NMDA)-receptor antagonists enhanced the head-twitch response induced by 5-hydroxytryptamine (5-HT) in reserpine-treated mice. To minimize the risk of any indirect involvement of NMDA-receptor antagonists (D(-)-2-amino-5-phosphonopentanoic acid (AP-5), D(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP), (+)-5-methyl-10,11-dihydroxy-5H-dibenzo-[a,d]-cyclohepten-5,10-imi ne (MK-801), ketamine, dextrorphan and dextromethorphan) with 5-HT neurones, vesicle stores of monoamines, especially 5-HT, were depleted with reserpine. In addition, the enhancement of 5-HT-induced head-twitch response was inhibited by apomorphine and NMDA as well as ritanserin in reserpine-treated mice. These results support our previous conclusion that NMDA receptors play important roles in the glutamatergic modulation of 5-HTergic function at the postsynaptic 5-HT2 receptors in mice ...
Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study. - D Sauer, P R Allegrini, A Cosenti, A Pataki, H Amacker, G E Fagg
Long-term learning and memory require long-lasting changes in the strength of specific synaptic connections between neurons (Martin et al., 2000; Kandel, 2001). These adaptive changes in synaptic efficacy are initiated by activity-dependent release of neurotransmitters from presynaptic nerve terminals and binding to their cognate postsynaptic receptors. In glutamatergic synapses of the hippocampus, many of the activity-dependent synaptic modifications require the participation of NMDA receptors, which are heteromultimeric ion channels composed of the NR1 subunit and one or more of the NR2A or NR2B subunits (Hollmann and Heinemann, 1994). NMDA receptor-dependent Ca2+ influx activates a cascade of biochemical events that lead to the activation of so-called immediate early genes (IEGs). IEGs regulate delayed onset of effector genes, coding for structural, growth-related, and synaptic proteins (Herdegen and Leah, 1998). A candidate molecule suggested to participate in learning and memory is the IEG ...
In the present study, N-methyl-D-aspartate receptor 2B (NR2B)-specific siRNA was applied in parkinsonian models. Our previous results showed that reduction in expression of N-methyl-D-aspartate receptor 1 (NR1), the key subunit of N-methyl-D-aspartate receptors, by antisense oligos ameliorated the motor symptoms in the 6-hydroxydopamine (6-OHDA)-lesioned rat, an animal model of Parkinsons disease (PD) [Lai et al.: Neurochem Int 2004;45:11-22]. To further the investigation on the efficacy of gene silencing, small interference RNA (siRNA) specific for the NR2B subunit was designed and administered in the striatum of 6-OHDA-lesioned rats. The present results show that administration of NR2B-specific siRNA decreased the number of apomorphine-induced rotations in the lesioned rats and that there was a significant reduction in NR2B proteins levels after NR2B-specific siRNA administration. Furthermore, attenuation of the loss of dopaminergic neurons was found in both the striatal and substantia nigra ...
Long-term potentiation (LTP) in the hippocampal CA1 region requires the activation of N-methyl-D-aspartate receptors (NMDARs). Studies using genetic and pharmacological approaches have reported inconsistent results of the requirement of NR2B-containing NMDARs in LTP in the CA1 region. Pharmacological studies showed that NR2B-containing NMDARs are not required for LTP, while genetic studies reported that over-expression of NR2B-NMDARs enhances LTP and hippocampus-dependent memory. Here, we provide evidence showing that the functional role of NR2B-NMDARs in hippocampal LTP and memory depends on LTP-inducing and behavior-conditioning protocols. Inhibition of NR2B-NMDARs with the NR2B selective antagonist ifenprodil or Ro25-6981 suppressed LTP induced by spike-timing protocol, with no impact on LTP induced by pairing protocol or two-train high-frequency stimulation (HFS) protocol. Inhibition of NR2B-NMDARs did not affect the late phase LTP induced by four-train HFS. Ca2+ imaging showed that there was
The N-methyl-d-aspartate receptor plays a critical role in the formation and maintenance of synapses during brain development. In the rodent, changes in subunit expression and assembly of the heteromeric receptor complex accompany these maturational processes. However, little is known about N-methyl-d-aspartate receptor subunit expression during human brain development. We used in situ hybridization to examine the distribution and relative abundance of NR1, NR2A and NR2B subunit messenger ribonucleic acids in the hippocampal formation and adjacent cortex of 34 human subjects at five stages of life (neonate, infant, adolescent, young adult and adult). At all ages, the three messenger ribonucleic acids were expressed in all subfields, predominantly by pyramidal neurons, granule cells and polymorphic hilar cells. However, their abundance varied across ontogeny. Levels of NR1 messenger ribonucleic acid in CA4, CA3 and CA2 subfields were significantly lower in the neonate than all other age groups. In the
The N-methyl-d-aspartate receptor plays a critical role in the formation and maintenance of synapses during brain development. In the rodent, changes in subunit expression and assembly of the heteromeric receptor complex accompany these maturational processes. However, little is known about N-methyl-d-aspartate receptor subunit expression during human brain development. We used in situ hybridization to examine the distribution and relative abundance of NR1, NR2A and NR2B subunit messenger ribonucleic acids in the hippocampal formation and adjacent cortex of 34 human subjects at five stages of life (neonate, infant, adolescent, young adult and adult). At all ages, the three messenger ribonucleic acids were expressed in all subfields, predominantly by pyramidal neurons, granule cells and polymorphic hilar cells. However, their abundance varied across ontogeny. Levels of NR1 messenger ribonucleic acid in CA4, CA3 and CA2 subfields were significantly lower in the neonate than all other age groups. In the
TY - JOUR. T1 - Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. AU - Perkinton, Michael S. AU - Ip, James K. AU - Wood, Gemma L. AU - Crossthwaite, Andrew J. AU - Williams, Robert J. PY - 2002. Y1 - 2002. N2 - Ca2+ influx through NMDA receptors can initiate molecular changes in neurones which may underlie synaptic plasticity, neuronal development, survival and excitotoxicity. Signalling through the MAP kinase (Erk1/2) cascade may be central to these processes. We previously demonstrated that Ca2+-permeable AMPA receptors activate Erkl/2 through a phosphatidylinositol 3-kinase (PI 3-kinase)-dependent mechanism. We now report that NMDA receptor activation of Erk1/2 was also blocked by inhibitors of PI 3-kinase (LY 294002, wortmannin). In addition, pre-treatment of neurones with pertussis toxin inhibited NMDA-induced Erk1/2 activation, indicating a role for heterotrimeric Gi/o proteins. PI 3-kinase ...
This study shows that NMDA receptor-driven plasticity, behavior, and signal transduction is mediated by the MAGUK protein SAP102. SAP102 was required for the induction or initiation of these signaling events consistent with its direct physical association with the receptor. Remarkable specificity in the signaling responses was observed, with only specific frequencies of synaptic activation requiring SAP102 and ERK pathways. Thus, the discrimination of different patterns of neuronal activity, all of which activate the NMDA receptor, is performed by distinct MAGUK proteins that then selectively engage downstream pathways. These results are consistent with published experiments showing MAGUK selectivity in relation to NMDA receptor subunits, downstream signaling, and plasticity effector mechanisms. Biochemical and electrophysiological evidence suggests that PSD-95 preferentially associates with NR2A-containing NMDA receptors, whereas SAP102 associates with NR2B-containing receptors (Sans et al., ...
GluN2B/NR2b glutamate receptor, also known as Glutamate/N-methyl D-aspartate/NMDA receptor subtype 2B, is a member of the NMDA receptor family. NMDA receptors are expressed throughout the CNS in postsynaptic cell membranes. GluN2B is a major NMDAR subtype found in cortical and hippocampal regions of the adult brain. NMDA receptors are involved with memory and learning. Mutations in the gene encoding GluN2B are associated with autism, LennoxGastaut and West Syndromes ...
QNZ46 is a NMDA receptor antagonist. QNZ46 inhibits NMDA receptor function in a noncompetitive and voltage-independent manner by an unconventional mechanism that requires binding of glutamate to the GluN2 subunit, but not glycine binding to the GluN1 subunit. QNZ46 could provide an opportunity for the development of pharmacological tools and therapeutic agents that target NMDA receptors at a new site and modulate function by a novel mechanism. NMDA receptors are ionotropic glutamate receptors that mediate excitatory synaptic transmission and have been implicated in several neurological diseases.
TY - JOUR. T1 - Nerve Growth Factor Uses Ras/ERK and Phosphatidylinositol 3-Kinase Cascades to Up-regulate the N-Methyl-D-aspartate Receptor 1 Promoter. AU - Liu, Anguo. AU - Prenger, Michael S.. AU - Norton, Darrell D.. AU - Mei, Lin. AU - Kusiak, John W.. AU - Bai, Guang. PY - 2001/11/30. Y1 - 2001/11/30. N2 - We reported previously that nerve growth factor (NGF) up-regulates activity of the N-methyl-D-aspartate receptor 1 (NR1) promoter. We have explored the pathways and nuclear targets of NGF signaling in regulating the NR1 promoter. PD98059 and wortmannin, but not rapamycin, significantly attenuated NGF-induced transcriptional activity from an NR1 promoter-luciferase construct. Coexpressing constitutively active forms of Ras, Raf, or MAPK/ERK kinase 1 (MEK1) increased promoter activity dramatically. The MEK1-induced increase was largely prevented by mutations of the tandem GC boxes in the promoter. Promoter activity was also increased significantly by coexpressed GC box-binding proteins ...
Ketamine, an FDA approved anesthetic agent, is becoming the sedative/analgesic of choice for emergency sedation in children because it causes deep sedation with minimal respiratory depression in comparison to other available agents. However, emergence reactions are an important adverse effect of ketamine, characterized by transient changes in cognitive function, dissociation and mild schizophrenia-like symptoms. These cognitive and behavioral effects are dose-dependently induced by ketamine and other antagonists of the N-methyl-D-aspartate (NMDA) glutamate receptor. NMDA receptor hypofunction can disinhibit excitatory (cholinergic/glutamatergic) projections in key areas of the brain, and this has been proposed to explain key features of schizophrenia. Several treatments that block excessive excitatory transmitter release have also been shown to prevent cognitive and behavioral effects of ketamine-induced NMDA receptor hypofunction in humans. Alpha-2 adrenergic agonists, which can presynaptically ...
Ketamine, an FDA approved anesthetic agent, is becoming the sedative/analgesic of choice for emergency sedation in children because it causes deep sedation with minimal respiratory depression in comparison to other available agents. However, emergence reactions are an important adverse effect of ketamine, characterized by transient changes in cognitive function, dissociation and mild schizophrenia-like symptoms. These cognitive and behavioral effects are dose-dependently induced by ketamine and other antagonists of the N-methyl-D-aspartate (NMDA) glutamate receptor. NMDA receptor hypofunction can disinhibit excitatory (cholinergic/glutamatergic) projections in key areas of the brain, and this has been proposed to explain key features of schizophrenia. Several treatments that block excessive excitatory transmitter release have also been shown to prevent cognitive and behavioral effects of ketamine-induced NMDA receptor hypofunction in humans. Alpha-2 adrenergic agonists, which can presynaptically ...
After cerebral ischemia, the loss of blood supply triggers a series of pathological changes known as ischemic cascades. One of the key components of this cascade is excitotoxicity, triggered by the excessive extracellular glutamate level, overactivation of N-methyl-D-aspartate (NMDA)-glutamate subty
NMDA receptors are glutamate- and glycine-gated channels that mediate fast excitatory transmission in the central nervous system and are critical to synaptic development, plasticity and integration. They have a rich complement of modulatory sites, which represent important pharmacologic targets. Ifenprodil is a well-tolerated NMDA receptor inhibitor; it is selective for GluN2B-containing receptors; and has neuroprotective effects. The mechanism by which ifenprodil inhibits NMDA receptor responses is not fully understood. The inhibition is incomplete and non-competitive with other known NMDA receptor agonists or modulators, although reciprocal effects have been reported between ifenprodil potency and that of extracellular ligands including glutamate, glycine, zinc, protons and polyamines. Recently, structural studies revealed that ifenprodil binds to a unique site at the interface between the extracellular N-termini of GluN1 and GluN2B subunits supporting the view that interactions with other ...
N-methyl-d-aspartate receptor (NMDAR) subunit composition strictly commands receptor function and pharmacological responses. Changes in NMDAR subunit composition have been documented in brain disorders such as Parkinsons disease (PD) and levodopa (L-DOPA)-induced dyskinesias (LIDs), where an increase of NMDAR GluN2A/GluN2B subunit ratio at striatal synapses has been observed. A therapeutic approach aimed at rebalancing NMDAR synaptic composition represents a valuable strategy for PD and LIDs. To this, the comprehension of the molecular mechanisms regulating the synaptic localization of different NMDAR subtypes is required. We have recently demonstrated that Rabphilin 3A (Rph3A) is a new binding partner of NMDARs containing the GluN2A subunit and that it plays a crucial function in the synaptic stabilization of these receptors. Considering that protein-protein interactions govern the synaptic retention of NMDARs, the purpose of this work was to analyse the role of Rph3A and Rph3A/NMDAR complex ...
TY - JOUR. T1 - Hypoxia modulates nitric oxide-induced regulation of NMDA receptor currents and neuronal cell death. AU - Gbadegesin, Muyiwa. AU - Vicini, Stefano. AU - Hewett, Sandra. AU - Wink, David A.. AU - Espey, Michael. AU - Pluta, Ryszard M.. AU - Colton, Carol A.. PY - 1999. Y1 - 1999. N2 - Nitric oxide (NO) released from a new chemical class of donors enhances N-methyl-D-aspartate (NMDA) channel activity. Using whole cell and single- channel patch-clamp techniques, we have shown that (Z)-1-[N(3-ammoniopropyl)- N-(n-propyl)amino]-NO (PAPA-NO) and diethylamine NO, commonly termed NONOates, potentiate the glutamate-mediated response of recombinant rat NMDA receptors(NR1/NR2A) expressed in HEK-293 cells. The overall effect is an increase in both peak and steady-state whole cell currents induced by glutamate. Single-channel studies demonstrate a significant increase in open probability but no change in the mean single-channel open time or mean channel conductance. Reduction in oxygen levels ...
We report here that brief exposure to 5-50 μM extracellular zinc, comparable to the concentrations estimated to be released normally into synaptic clefts (4), selectively enhanced the phosphorylation of neuronal Src at tyrosine 220 in the SH2 domain, without affecting tyrosine phosphorylation of Fyn. This phosphorylation was accompanied by increases in Src activity, NMDA receptor phosphorylation, and NMDA receptor function (current and excitotoxicity). Drawing on key earlier studies as well as present measurements of [Na+]i in neurons exposed to zinc, we propose that the ability of zinc to induce this up-regulation of Src activity and NMDA receptor function is mediated by inhibition of plasma membrane Na+/K+ ATPase and elevated [Na+]i. Although low concentrations of zinc can potentiate current mediated by certain homomeric NMDA receptor subunit 1 (NR1) splice variants, zinc potentiation of more physiological heteromeric NR1/NR2 receptors was not previously observed (70, 71).. No change in the ...
TY - JOUR. T1 - Na+ occupancy and Mg2+ block of the N-methyl-D-aspartate receptor channel. AU - Zhu, Yongling. AU - Auerbach, Anthony. PY - 2001. Y1 - 2001. N2 - The effect of extracellular and intracellular Na+ on the single-channel kinetics of Mg2+ block was studied in recombinant NR1-NR2B NMDA receptor channels. Na+ prevents Mg2+ access to its blocking site by occupying two sites in the external portion of the permeation pathway. The occupancy of these sites by intracellular, but not extracellular, Na+ is voltage-dependent. In the absence of competing ions, Mg2+ binds rapidly (,108 M-1s-1, with no membrane potential) to a site that is located 0.60 through the electric field from the extracellular surface. Occupancy of one of the external sites by Na+ may be sufficient to prevent Mg2+ dissociation from the channel back to the extracellular compartment. With no membrane potential; and in the absence of competing ions, the Mg2+ dissociation rate constant is ,10 times greater than the Mg2+ ...
Dr. Graham L. Collingridge accepted the invitation on 18 March 2007 (self-imposed deadline: 18 June 2007). This article will briefly cover: The discovery of the NMDA receptor, its unusual properties (Mg block, slow kinetics, Ca permeability, voltage-dependence, glycine co-agonist site), its role in synaptic transmission, synaptic plasticity and diseases. The NMDA receptor is one of the four major classes of receptors that respond to L-glutamate, the major excitatory neurotransmitter in the brain. It is named after the synthetic chemical N-methyl-D-aspartate, which is a highly selective agonist for this receptor. THe NMDA receptor (NMDAR) has unique properties that distinguishes it from the other three major glutamate receptor classes - AMPA receptors, kainate receptors and metabotropic receptors. The NMDAR is a tetramer, which is made up from various combinations of the subunits NR1, NR2A, NR2B, NR2C, NR2D, NR3A and NR3B. Most NMDARs contain 2 NR1 subunits, which bind the co-agonist glycine and ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show neuroprotective efficacy in human clinical trials or produced intolerable central nervous system adverse effects. The failure of these agents has been attributed to poor studies in animal models and to poorly designed clinical trials. We also speculate that NMDA receptor antagonism may have hindered endogenous mechanisms for neuronal survival and neuroregeneration. It remains to be proven in human stroke whether NMDA receptor antagonism can be neuroprotective.
Sigma-Aldrich offers abstracts and full-text articles by [Liana Roberts Stein, Charles F Zorumski, Shin-Ichiro Imai, Yukitoshi Izumi].
TY - JOUR. T1 - Prenatal NMDA receptor antagonism impaired proliferation of neuronal progenitor, leading to fewer glutamatergic neurons in the prefrontal cortex. AU - Toriumi, Kazuya. AU - Mouri, Akihiro. AU - Narusawa, Shiho. AU - Aoyama, Yuki. AU - Ikawa, Natsumi. AU - Lu, Lingling. AU - Nagai, Taku. AU - Mamiya, Takayoshi. AU - Kim, Hyoung Chun. AU - Nabeshima, Toshitaka. N1 - Funding Information: We thank Dr Furukawa H for synthesizing PCP. This study was supported by Grants-in-aid for Scientific Research (A) (22248033), Scientific Research (B) (20390073) (21390045) and Exploratory Research from the JSPS (19659017) (22659213); by the Academic Frontier Project for Private Universities (2007-2011) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); by Regional Joint Research Program supported by grants to Private Universities to Cover Current Expenses from MEXT; by Research on Regulatory Science of Pharmaceuticals and Medical Devices from the Ministry of ...
Neuroprotective efficiency of NMDA receptor blockade in the striatum and CA3 hippocampus after various durations of cerebral ischemia in gerbils. - L Radenovic, V Selakovic, B Janac, Pavle R Andjus
In a recent BNN article on potential drugs for memory loss, we omitted two conventional classes of drugs used to treat Alzheimers Disease-acetylcholine esterase inhibitors (AChE-Is) and the blocker of glutamate NMDA receptors memantine (Namenda). This was intentional, as we hoped to suggest possible approaches prior to the use of these drugs for full-blown dementia. However, we neglected to cite a 1999 study by Fred Jacobsen in the Journal of Clinical Psychiatry that indicated that the AChE-I drug donepezil (Aricept) was effective in improving drug-induced memory dysfunction in patients without dementia. Side effects included insomnia, nausea, vomiting, and diarrhea.. Jacobsen has used AChE-Is to improve memory in over 80 patients with unipolar or bipolar depression, aged 19-85. In a 2016 personal communication to the BNN, he indicated that doses of 5mg/day are typically enough to improve memory. Higher doses of 10mg/day may be more effective, but increase the risk of switching into mania for ...
Qin S, Zhao X, Pan Y, Liu J, Feng G, Fu J, Bao J, Zhang Z, He L. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur J Hum Genet. 2005 Jul;13(7):807-14.. Thornton-Wells TA, Moore JH, Martin ER, Pericak-Vance MA, Haines JL. Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis. Genet Epidemiol. 2008 Apr;32(3):187-203.. Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, Carracedo A, Martorell L, Valero J, Labad A, De Frutos R, Najera C, Molto MD, Toirac I, Guillamat R, Brunet A, Valles V, Perez L, Leon M, de Fonseca FR, Phillips C, Torres M. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res. 2008 Mar;42(4):278-88.. Yasuno K, Ando S, Misumi S, Makino S, Kulski JK, Muratake T, Kaneko N, Amagane H, Someya T, Inoko H, Suga H, ...
NMDA receptors are hetero-oligomers assembled from two typesof subunits, NR1 and NR2. The NR1 subunit is a single geneproduct, whereas the NR2 subunit is encoded by four differentgenes: NR2A-NR2D (147). Native NMDA receptors are thoughtto be heteromultimers containing four or five subunits consistingof two NR1 subunits and two or three NR2 subunits (38). Atmost synapses throughout the central nervous system, NMDA receptorsare composed of NR1 subunits in combination with either NR2Aor NR2B subunits. NR2A and NR2B subunits are ubiquitously distributedthrough the central nervous system and have been shown to undergoa developmental switch in hippocampal and cortical neurons(179). At birth NMDA receptors are composed of NR1/NR2B subunits,and there is a switch from NR2B to NR2A subunits around P7.However, in the LA, a recent study has shown that applicationof the NR2B-selective antagonist ifenprodil blocks the inductionof fear conditioning, suggesting that receptors containingNR2B subunits are present ...
Ultiva® is commonly administered intravenously through standard anaesthesia. IbrutinibIts key constituent is remifentanil, a potent small-performing μ-opioid receptor agonist. Despite the fact that behavioural research in rats counsel that intrathecal administration of remifentanil induces profound analgesia, Ultiva® is not authorized for epidural or intrathecal use in medical observe.The medical formulation of Ultiva® is made up of glycine as an acidic buffer. Glycine is a main inhibitory neurotransmitter in the central anxious system, and is also an significant N-methyl-D-aspartate receptor co-activator with glutamate the latter motion is proposed as a likely mechanism for opioid-induced hyperalgesia. It has also been suggested that remifentanil by itself may well straight boost NMDA receptor-mediated responses in the dorsal horn and market hyperalgesia.Though these results counsel that intrathecal administration of Ultiva® might have contrary professional-nociceptive and anti-nociceptive ...
Ultiva® is commonly administered intravenously through standard anaesthesia. IbrutinibIts key constituent is remifentanil, a potent small-performing μ-opioid receptor agonist. Despite the fact that behavioural research in rats counsel that intrathecal administration of remifentanil induces profound analgesia, Ultiva® is not authorized for epidural or intrathecal use in medical observe.The medical formulation of Ultiva® is made up of glycine as an acidic buffer. Glycine is a main inhibitory neurotransmitter in the central anxious system, and is also an significant N-methyl-D-aspartate receptor co-activator with glutamate the latter motion is proposed as a likely mechanism for opioid-induced hyperalgesia. It has also been suggested that remifentanil by itself may well straight boost NMDA receptor-mediated responses in the dorsal horn and market hyperalgesia.Though these results counsel that intrathecal administration of Ultiva® might have contrary professional-nociceptive and anti-nociceptive ...
Dr. Jonathan Ploski focuses his research on developing clinically effective methods to therapeutically attenuate maladaptive emotional memories. He recently has been examining how the NMDA receptor subunit composition can influence the ability of an existing memory to be modified via reconsolidation updating. Specifically, Dr. Ploski has developed a line of transgenic mice that could specifically overexpress the GluN2A subunit of the NMDA receptor after a memory has been formed. Subsequently, he has found that when the GluN2A subunit is overexpressed, the modification of an existing memory is prevented. Dr. Ploski also has developed a viral-based, inducible CRISPR/Cas9 system for in vivo genome editing that can be used for studies focused on the role of specific genes and behavior. His lab has received a seed grant from the Texas Medical Device Center to develop a viral delivered inducible genome editing system that will facilitate the investigation of how particular genes influence neural ...
In the 1960s and 70s, biochemical and pharmacological evidence was pointing toward glutamate as a synaptic transmitter at a number of distinct receptor classes, known as NMDA and non-NMDA receptors. The field, however, lacked a potent and highly selective antagonist to block these putative postsynaptic receptors. So, the discoveries in the early 1980s of D-AP5 as a selective NMDA receptor antagonist and of its ability to block synaptic events and plasticity were a major breakthrough leading to an explosion of knowledge about this receptor subtype. During the next 10 years, the role of NMDA receptors was established in synaptic transmission, long-term potentiation, learning and memory, epilepsy, pain, among others. Hints at pharmacological heterogeneity among NMDA receptors were followed by the cloning of separate subunits. The purpose of this review is to recognize the important contributions made in the 1980s by Graham L. Collingridge and other key scientists to the advances in our ...
Results-In both in vitro and in vivo ischemia models, glycine at low level exerts deleterious effects in postischemic long-term potentiation and ischemic neuronal injury by modulation of the N-methyl-d-aspartate receptor coagonist site; whereas glycine at high level exerts neuroprotective effects by activation of glycine receptor and subsequent differential regulation of N-methyl-d-aspartate receptor subunit components. Read more. ...
El óxido nítrico (NO) es una molécula con efectos pleyotrópicos en cerebro y sistema vascular. Fisiológicamente, induce la traducción de la subunidad GluN2B del N-methyl D-aspartate receptor (NMDARc) al revertir la represión de su 5untranslated region (5UTR). Este efecto se debe a la activación de la heme regulated eIF2α kinase (HRI) y previene el exceso de GluN2B, especialmente en regiones extrasinápticas, donde desencadena excitotoxicidad. Patológicamente, el NO en un ambiente pro-oxidatvio como el dado en la enfermedad de Alzheimer (AD) reacciona con el anión superóxido produciendo peroxinitrito, y causando entre otros efectos la nitrotirosinación de proteínas. Simultaneamente, las proteínas de pacientes con AD padecen otros procesos oxidativos como la glicación. Por tanto, la albúmina, la proteína plasmática más abundante, en estos pacientes está más nitrotirosinada y glicada, afectando su estructura. La albúmina modificada presenta menos capacidad para tamponar la ...
AbstractIn the present study, a twenty-mer antisense oligonucleotide specific for N-methyl-D-aspartate receptor one (ANR1) was applied to striatal neurons in primary cell culture. The ANR1 was found to be specific and nontoxic. Significant reductions in expression of NR1 mRNA and proteins were resulted after a single dose of ANR1 transcripts. Interestingly, there were reductions in total NR1 proteins but two phosphorylated forms of NR1 proteins at serine 896 and 897 residues were not reduced. There was also no change in the pattern of distribution of NR1 immunoreactivity in the striatal neurons. In addition, significant reductions of NMDA-mediated peak inward current were found after application of a higher concentration of ANR1 (20-100 mu M) by patch clamp recordings. The present results indicate that ANR1 is a useful agent in reducing NMIDA receptor functions. The present data thus provide detailed cellular and molecular mechanisms to explain our previous findings of amelioration of motor ...
Looking for online definition of N-methyl D-aspartate receptor subtype 2C in the Medical Dictionary? N-methyl D-aspartate receptor subtype 2C explanation free. What is N-methyl D-aspartate receptor subtype 2C? Meaning of N-methyl D-aspartate receptor subtype 2C medical term. What does N-methyl D-aspartate receptor subtype 2C mean?
Aggregates of amyloid-beta (Aβ) and tau are hallmarks of Alzheimers disease (AD) leading to neurodegeneration and synaptic loss. While increasing evidence suggests that inhibition of N-methyl-D-aspartate receptors (NMDARs) may mitigate certain aspects of AD neuropathology, the precise role of different NMDAR subtypes for Aβ- and tau-mediated toxicity remains to be elucidated. Using mouse organotypic hippocampal slice cultures from arcAβ transgenic mice combined with Sindbis virus-mediated expression of human wild-type tau protein (hTau), we show that Aβ caused dendritic spine loss independently of tau. However, the presence of hTau was required for Aβ-induced cell death accompanied by increased hTau phosphorylation. Inhibition of NR2B-containing NMDARs abolished Aβ-induced hTau phosphorylation and toxicity by preventing GSK-3β activation but did not affect dendritic spine loss. Inversely, NR2A-containing NMDAR inhibition as well as NR2A-subunit knockout diminished dendritic spine loss ...
Hypertension is major risk factor leading to cerebrovascular pathologies. N-methyl d-aspartate receptors (NMDARs) and renin-angiotensin system are involved in neuronal plasticity, as well as cognitive functions in the hippocampus. In this study, we examined the effects of lisinopril, an ACE inhibitor, on the levels of hippocampal NMDAR subunits; NR2A and NR2B in L-NAME (N-epsilon-nitro-l-arginine Methyl Ester)-induced hypertensive rats. In addition, malondialdehyde (MDA) levels were measured as a marker for lipid peroxidation. Compared with the control group, the MDA level was significantly increased after 8 weeks in the l-NAME-treated group. Rats treated with lisinopril and l-NAME plus lisinopril were found to have significantly decreased hippocampal MDA levels. Regarding the hippocampal concentrations of NR2A and NR2B, there were no statistically significant differences between groups. We demonstrated that lisinopril treatment has no direct regulatory effect on the levels of NR2A and NR2B in ...
Generalizations of NMDA-receptor antagonists to the discriminative stimulus effects of κ-opioid receptor agonists in rats were examined. Phencyclidine, MK-801, and ketamine, non-competitive NMDA-receptor antagonists, generalized to the discriminative stimulus effects of U-50,488H, but not those of TRK-820, whereas (±)-3-(2-carbaxypiperazine-4-yl) propyl-1-phosphonic acid (CPP), a competitive NMDA-receptor antagonist, and ifenprodil, an NR1/NR2B NMDA-receptor antagonist, did not, suggesting that non-competitive NMDA-receptor antagonists possess U-50,488H-like discriminative stimulus effects in rats. Since U-50,488H and phencyclidine both induce aversive effects, our findings indicate that the cue of the discriminative stimulus effects of U-50,488H and non-competitive NMDA-receptor antagonists may be associated with their aversive effects.,br,. ...
Cerebellar granule cells are susceptible to the excitotoxin glutamate, which acts at N-methyl-D-aspartate (NMDA) receptors, as well as the neurotoxin 1-methyl-4-phenylpyridinium ion (MPP+), the active cytotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Paradoxically, preincubation of cultured cerebellar granule cells with low concentrations of NMDA or glutamate markedly antagonizes the neurotoxicity resulting from subsequent exposure to toxic concentrations of either MPP+ or glutamate. The neuroprotective effects of NMDA and glutamate against MPP+ toxicity are observed at agonist concentrations as low as 1 microM, are blocked by specific NMDA receptor antagonists, and require at least 30 min to develop fully. Moreover, NMDA receptor-mediated neuroprotection is prevented by the RNA synthesis inhibitor actinomycin D or the protein synthesis inhibitor cycloheximide. Thus, in cerebellar granule cells activation of NMDA receptors by glutamate can result in either ...
TY - JOUR. T1 - NMDA receptor blockade prevents the increase in protein kinase C substrate (protein F1) phosphorylation produced by long-term potentiation. AU - Linden, David J.. AU - Wong, Ka L.. AU - Sheu, Fwu Shan. AU - Routtenberg, Aryeh. PY - 1988/8/16. Y1 - 1988/8/16. N2 - Recent evidence has implicated activation of the N-methyl-d-aspartate (NMDA) class of glutamate receptor in the initiation of hippocampal long-term potentiation (LTP), an electrophysiological model of information storage in the brain. A separate line of evidence has suggested that activation of protein kinase C (PKC) and the consequent phosphorylation of it substrates is necessary for the maintenance of the LTP response. To determine if PKC activation is a consequence of NMDA receptor activation during LTP, we applied the NMDA receptor antagonist drug, dl-aminophosphonovalerate (APV) both immediately prior to and following high frequency stimulation, resulting in successful and unsuccessful blockade of LTP initiation, ...
One of the first cognitive dysfunctions to arise with aging is memory loss, affecting an estimated 85% of elderly in the U.S. over the age of 80 with Age Associated Memory Impairment. A common feature in humans and animals experiencing memory loss with aging is the decline in N-methyl-D-aspartate (NMDA) receptorbinding densities in the brain. Variability in the effects of aging on the GluN1 subunit suggests that inflammation may play a role in NMDA receptor aging. The purpose of the present study was to determine the effects of an anti-inflammatory drug, ibuprofen, on spatial long-term & short-term memory and cognitive flexibility in male C57BL/6 mice from four different age groups (5, 14, 20, and 26 months of age at the end of testing). Mice were fed either Ibuprofen (375 ppm) in NIH31 diet or NIH31 diet alone for 6 weeks prior to testing. This dose had been shown to reduce pathology in an Alzheimers disease mouse model. Behavioral testing using the Morris Water Maze showed a significant ...
Alpha-actinin (alpha-actinin-2) is a protein which links the NR1 and NR2B subunits of N-methyl-D-aspartate (NMDA) glutamate receptors to the actin cytoskeleton. Because of the importance of NMDA receptors in modulating the function of the striatum, we have examined the localization of alpha-actinin-2 protein and mRNA in striatal neurons, and its biochemical interaction with NMDA receptor subunits present in the rat striatum. Using an alpha-actinin-2-specific antibody, we found intense immunoreactivity in the striatal neuropil and within striatal neurons that also expressed parvalbumin, calretinin and calbindin. Conversely, alpha-actinin-2 immunoreactivity was not detected in neurons expressing choline acetyltransferase and neuronal nitric oxide synthase. Dual-label in situ hybridization revealed that the highest expression of alpha-actinin-2 mRNA is in substance P-containing striatal projection neurons. The alpha-actinin-2 mRNA is also present in enkephalinergic projection neurons and ...
Abundant evidence suggests that NMDA receptors are involved in the nociceptive responses to formalin. Pretreatment with a competitive NMDA receptor antagonist [e.g., APV[3-amino-5-phosphonovaleric acid] or a noncompetitive NMDA receptor antagonist {e.g.,MK-801, [(+)-5 methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate], dextromethorphan or ketamine} reduces nociceptive behavioral and/or electrophysiological responses induced by formalin (Coderre and Melzack, 1992; Haley et al., 1990;Yamamoto and Yaksh, 1992; Vaccarino et al., 1993; Hunter and Singh, 1994; Elliott et al., 1995; Shimoyama et al., 1996). The effects of NMDA receptor antagonists are primarily on phase 2 behaviors of the formalin response (Coderre and Melzack, 1992). Phase 2 of the formalin test appears to reflect central sensitization. The barrage of C-fiber inputs produced by formalin most likely activates spinal cord NMDA receptors, which results in the sensitization of dorsal horn neurons. This results ...
We asked whether GABA(A) and NMDA receptors may act in synergy in neonatal hippocampal slices, at a time when GABA exerts a depolarizing action. The GABA(A) receptor agonist isoguvacine reduced the voltage-dependent Mg2+ block of single NMDA channels recorded in cell-attached configuration from P(2-5) CA3 pyramidal neurons and potentiated the Ca2+ influx through NMDA channels. The synaptic response evoked by electrical stimulation of stratum radiatum was mediated by a synergistic interaction between GABA(A) and NMDA receptors. Network-driven Giant Depolarizing Potentials, which are a typical feature of the neonatal hippocampal network, provided coactivation of GABA(A) and NMDA receptors and were associated with spontaneous and synchronous Ca2+ increases in CA3 pyramidal neurons. Thus, at the early stages of development, GABA is a major excitatory transmitter that acts in synergy with NMDA receptors. This provides in neonatal neurons a hebbian stimulation that may be involved in neuronal plasticity and
TY - JOUR. T1 - Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. AU - Skeberdis, Vytenis A.. AU - Lan, Jian Yu. AU - Zheng, Xin. AU - Zukin, R. Suzanne. AU - Bennett, Michael V.L.. N1 - Copyright: Copyright 2007 Elsevier B.V., All rights reserved.. PY - 2001/3/13. Y1 - 2001/3/13. N2 - Insulin potentiates N-methyl-D-aspartate receptors (NMDARs) in neurons and Xenopus oocytes expressing recombinant NMDARs. The present study shows that insulin induced (i) an increase in channel number times open probability (nPo) in outside-out patches excised from Xenopus oocytes, with no change in mean open time, unitary conductance, or reversal potential, indicating an increase in n and/or Po;; (ii) an increase in charge transfer during block of NMDA-elicited currents by the open channel blocker MK-801, indicating increased number of functional NMDARs in the cell membrane with no change in Po;; and (iii) increased NR1 surface expression, as indicated by Western ...
Dopamine and the excitatory amino acids play important roles in the control of motor behavior by the basal ganglia; elucidating the manner in which these transmitter systems interact may provide new therapeutic approaches to the treatment of movement disorders such as Parkinsons disease. The 2-deoxyglucose autoradiographic technique was used to examine the effect of N-methyl-D-aspartate receptor blockade on regional cerebral metabolic responses to D1 and D2 dopamine receptor stimulation in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway. The D1 agonist SKF 38393 (5 mg/kg, i.v.) increased glucose utilization markedly in entopeduncular nucleus and substantia nigra pars reticulata ipsilateral to the lesion, while the D2 agonist quinpirole (1 mg/kg, i.v.) had no effect in these striatal output regions. SKF 38393 and quinpirole reduced 2-deoxyglucose uptake to a similar extent in the lateral habenula, a region which receives afferent input from entopeduncular nucleus; quinpirole
Ananth, C., Dheen, S.T., Gopalakrishnakone, P., Kaur, C. (2003). Distribution of NADPH-diaphorase and expression of nNOS, N-Methyl-D-Aspartate receptor (NMDAR1) and Non-NMDA glutamate receptor (GlutR2) genes in the neurons of the hippocampus after domoic acid-induced lesions in adult rats. Hippocampus 13 (2) : 260-272. [email protected] Repository. https://doi.org/10.1002/hipo. ...
TY - JOUR. T1 - Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo. AU - Quinlan, Elizabeth M.. AU - Philpot, Benjamin D.. AU - Huganir, Richard L.. AU - Bear, Mark F.. PY - 1999/4/1. Y1 - 1999/4/1. N2 - Sensory experience is crucial in the refinement of synaptic connections in the brain during development. It has been suggested that some forms of experience-dependent synaptic plasticity in vivo are associated with changes in the complement of postsynaptic glutamate receptors, although direct evidence has been lacking. Here we show that visual experience triggers the rapid synaptic insertion of new NMDA receptors in visual cortex. The new receptors have a higher proportion of NR2A subunits and, as a consequence, different functional properties. This effect of experience requires NMDA receptor activation and protein synthesis. Thus, rapid regulation of post- synaptic glutamate receptors is one mechanism for developmental plasticity in the brain. Changes in ...
Experimental and clinical studies showed that intraoperative infusionof remifentanil has been associated with postoperative hyperalgesia. Previous reports suggested that spinal N-methyl-D-aspartate (NMDA) receptors may contribute to the development and maintenance of opioid-induced hyperalgesia. In the present study, we used a rat model of postoperative pain to investigate the role of tyrosine phosphorylation of NMDA receptor 2B (NR2B) subunit in spinal cord in the postoperative hyperalgesia induced by remifentanil and the intervention of pretreatment with ketamine. Intraoperative infusion of remifentanil (0.04 mg/kg, subcutaneous) significantly enhanced mechanical allodynia and thermal hyperalgesia induced by the plantar incision during the postoperative period (each lasting between 2 h and 48 h), which was attenuated by pretreatment with ketamine (10 mg/kg, subcutaneous). Correlated with the pain behavior changes, immunocytochemical and western blotting experiments in our study revealed that there was
The BDNF secretion can be either constitutive or, more frequently, regulated by stimuli.32 This activity-dependent secretion, a feature characteristic of BDNF and not of any other neurotrophin or growth factor,33 may be an important factor in mood regulation. Along with slow effects that require protein synthesis, BDNF exerts rapid signaling events that regulate synaptic plasticity.34 For example, inducing phosphorylation of synapsin and thereby increasing glutamate and GABA release.35 BDNF can also increase ion influx through N-methyl-D-aspartate receptors and then synaptic strength.36 Thus, BDNF is able to regulate synaptic plasticity and recent findings suggest that mood disorders would be associated with alterations in information processing within neural networks.37 A large proportion of neuronal BDNF is secreted in the pro-form (proBDNF) which is subsequently converted to the mature form (mBDNF) by endoproteolytic cleavage.38 Lee et al.39 suggested that the extracellular conversion from ...
Although the importance of NMDARs as a therapeutic target for certain types of neuropathic pain has been well recognized, very few studies have directly examined changes in NMDAR activity in the spinal dorsal horn in different neuropathic pain conditions. We found that nerve injury induced a substantial increase in the amplitudes of NMDAR-EPSCs and postsynaptic NMDAR currents elicited by NMDA puff application in spinal lamina II neurons 3 weeks, but not 3 and 7 days, after SNL. Interestingly, we found that the postsynaptic NMDAR currents were much smaller in lamina I than in lamina II neurons and that nerve injury had no significant effect on NMDAR activity of lamina I neurons. These data indicate that nerve injury-induced increases in postsynaptic NMDAR activity in the spinal dorsal horn are time dependent and lamina specific. By analyzing the decay time of NMDAR-EPSCs and using selective GluN2A and GluN2B blockers, we showed that increased NMDAR activity of lamina II neurons by nerve injury is ...
Cultures of fetal hippocampal neurons were prepared according to the previously described techniques (MacDonald et al., 1989). Briefly, timed-pregnant mice were killed by cervical dislocation. Fetuses were removed, and hippocampi were microdissected and placed in cold Hanks solution. The hippocampi were then mechanically dissociated by trituration and plated in 35-mm, collagen-coated, culture dishes at densities of ,1 × 106 cells/ml. The cells were grown in dissociated tissue culture using standard techniques. The cultures were used for electrophysiological recordings 12-17 days after plating. The culture medium was replaced with extracellular solution before recording.. Acutely isolated hippocampal neurons were obtained as described previously (Jarvis et al., 1997). Rats (approximately 2 weeks of age) were anesthetized with halothane and killed by decapitation using a guillotine. The whole brain was removed and placed in cold extracellular solution (see below for composition). Hippocampi were ...
Hippocampal long-term potentiation (LTP), a long-lasting increase in synaptic efficacy, is the molecular basis for learning and memory. Tetanic stimulation of afferents in the CA1 region of the hippocampus induces glutamate release and activation of glutamate receptors in dendritic spines. A large increase in [Ca2+]i resulting from influx through NMDA receptors leads to constitutive activation of CaM kinase II (CaM KII) . Constitutively active CaM kinase II phosphorylates AMPA receptors, resulting in potentiation of the ionic conductance of AMPA receptors. Early-phase LTP (E-LTP) expression is due, in part, to this phosphorylation of the AMPA receptor. It is hypothesized that postsynaptic Ca2+ increases generated through NMDA receptors activate several signal transduction pathways including the Erk/MAP kinase and cAMP regulatory pathways. The convergence of these pathways at the level of the CREB/CRE transcriptional pathway may increase expression of a family of genes required for late-phase LTP ...
Hippocampal long-term potentiation (LTP), a long-lasting increase in synaptic efficacy, is the molecular basis for learning and memory. Tetanic stimulation of afferents in the CA1 region of the hippocampus induces glutamate release and activation of glutamate receptors in dendritic spines. A large increase in [Ca2+]i resulting from influx through NMDA receptors leads to constitutive activation of CaM kinase II (CaM KII) . Constitutively active CaM kinase II phosphorylates AMPA receptors, resulting in potentiation of the ionic conductance of AMPA receptors. Early-phase LTP (E-LTP) expression is due, in part, to this phosphorylation of the AMPA receptor. It is hypothesized that postsynaptic Ca2+ increases generated through NMDA receptors activate several signal transduction pathways including the Erk/MAP kinase and cAMP regulatory pathways. The convergence of these pathways at the level of the CREB/CRE transcriptional pathway may increase expression of a family of genes required for late-phase LTP ...
TY - JOUR. T1 - Age dependence of homosynaptic non-NMDA mediated long-term depression in field CA1 of rat hippocampal slices. AU - Velíšek, Libor. AU - Moshé, Solomon L.. AU - Stanton, Patric K.. PY - 1993/10/15. Y1 - 1993/10/15. N2 - It has been hypothesized that high levels of presynaptic activity that fail to activate postsynaptic N-methyl-d-aspartate (NMDA) receptors may lead to long-term depression (LTD). Therefore, we tested the ability of high-frequency (50 Hz) synaptic stimulation in the presence of a blocker of NMDA receptors to elicit homosynaptic LTD at Schaffer collateral-CA1 synapses in hippocampal slices from 15-, 30- and 60-day-old rats. In control slices, there were no developmental differences in the incidence of long-term potentiation (LTP) of either EPSP slope or population spike amplitude. However, while NMDA receptor blockade with the specific antagonist d-2-amino-5-phosphonopentanoic acid (AP5; 25 μM) completely eliminated LTP in 30 and 60-day-olds, a significant number ...
To monitor changes in alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor distribution in living neurons, the AMPA receptor subunit GluR1 was tagged with green fluorescent protein (GFP). This protein (GluR1-GFP) was functional and was transiently expressed in hippocampal CA1 neurons. In dendrites visualized with two-photon laser scanning microscopy or electron microscopy, most of the GluR1-GFP was intracellular, mimicking endogenous GluR1 distribution. Tetanic synaptic stimulation induced a rapid delivery of tagged receptors into dendritic spines as well as clusters in dendrites. These postsynaptic trafficking events required synaptic N-methyl-D-aspartate (NMDA) receptor activation and may contribute to the enhanced AMPA receptor-mediatedtransmission observed during long-term potentiation and activity-dependent synaptic maturation.. ...
The aim of the present thesis was firstly to investigate whether the behavioural deficit resulting from NMDA receptor blockade reflects a genuine learning impairment, rather than a disturbance of some other aspect of brain functioning. The behavioural test used was a reference memory task in the watermaze, the learning of which is highly sensitive to hippocampal dysfunction. It has been claimed that he apparent learning deficits caused by the application of NMDA receptor antagonists may be secondary to sensorimotor disturbances, or drug-induced brain damage. Behavioural and histological analysis in the present study was not consistent with either of these two possibilities. However, owing to the fact that NMDA receptor blockade does indeed cause a number of side effects, subsequent experiments investigated the role of a novel class of receptor, the metabotropic glutamate receptor (mGluR), in both LTP and spatial learning. Previous studies have suggested that mGluR activation is necessary for ...
The present study examined the regional differences in dopamine transporter binding sites and NMDA receptor complex binding based on autoradiographic images obtained in postmortem sections of human normal brain tissues. in middle-aged control tissues, high and comparable levels of [H-3]CFT binding were observed in the caudate nucleus, putamen, and accumbens nucleus without significant alteration along the rostrocaudal axis and ventral and dorsal parts of these nuclei. in aging normal brain tissues, dopamine binding sites for [H-3]CFT were significantly reduced in the caudate nucleus, putamen, and accumbens nucleus. L-[H-3]Glutamate, [H-3]MK-801, and [H-3]glycine binding to the NMDA receptor complex was lower in aging brain tissues than in middle-aged controls. Significant correlation did occur between age and [H-3]CFT binding and between age and L-[H-3]glutamate, [H-3]MK-801, and [H-3]glycine binding sites. These results demonstrate that the basal ganglia have age-associated reductions in ...
During cortical development, NMDA receptors (NMDARs) facilitate presynaptic terminal formation, enhance neurotransmitter release, and are required in presynaptic neurons for spike timing-dependent LTD. However, the extent to which NMDARs are found within cortical presynaptic terminals has remained controversial, and the sub-synaptic localization and dynamics of axonal NMDARs are unknown. Here, using live confocal imaging and biochemical purification of presynaptic membranes, we provide strong evidence that NMDARs localize to presynaptic terminals in vitro and in vivo, in a developmentally regulated manner. NR1 and NR2B subunits are found within the active zone membrane, where they could respond to synaptic glutamate release. Surprisingly, NR1 also appears in glutamatergic and GABAergic synaptic vesicles. During synaptogenesis, NR1 is mobile throughout axons - including growth cones and filopodia, structures that are involved in synaptogenesis. Upon synaptogenic contact, NMDA receptors are ...
1. Non‐competitive antagonists at the glutamatergic N‐methyl D‐ aspartate receptor significantly reduce the volume of ischaemic cerebral infarction in animals and are potential agents for the treatment of acute stroke in humans. 2. CNS 1102, a novel non‐ competitive NMDA antagonist, was administered as a 15 min intravenous infusion to healthy male volunteers in a double‐blind, placebo‐ controlled, dose‐ranging study. This was the first administration to man. 3. Clinically significant sedation, increased mean arterial pressure and pulse rate were seen at doses of 30 micrograms kg‐1 and above. Symptoms of sedation and central nervous excitation became unacceptable for conscious individuals at doses of 45 micrograms kg‐1 and above. 4. Rapid onset of central nervous system effects after administration is in keeping with rapid distribution of CNS 1102 to brain. Steady state volume of distribution was large (444 l) and terminal elimination half‐life from plasma was approximately 4 ...
TY - JOUR. T1 - Neuronal and glial localization of NMDA receptors in the cerebral cortex. AU - Conti, Fiorenzo. AU - Minelli, Andrea. AU - DeBiasi, Silvia. AU - Melone, Marcello. PY - 1997/2. Y1 - 1997/2. N2 - The crucial role of glutamate receptors of the N-methyl-D-aspartate (NMDA) type in many fundamental cortical functions has been firmly established, as has its involvement in several neuropsychiatric diseases, but until recently, very little was known of the anatomical localization of NMDA receptors in the cerebral cortex of mammals. The recent application of molecular biological techniques to the study of NMDA receptors has allowed the production of specific tools, the use of which has much increased our understanding of the localization of NMDA receptors in the cerebral cortex. In particular, immunocytochemical studies on the distribution of cortical NMDA receptors have: 1. Demonstrated the preferential localization of NMDA receptors in dendritic spines, in line with previous work; 2. ...
Deficiency of Insulin-like growth factor (IGF)--1 hormone may contribute to the genesis of cognitive impairment and dementia in the elderly patients. Old age, in the absence of circulating IGF-1, a hormone with a complex role in brain function have linked IGF-1 to an acceleration of neurological diseases(f). Growth hormone and IGF-1 replacement showed to increase neurogenesis, vascular density, and glucose utilization, and alters NMDA receptor subunit composition in brain areas that are implicated in learning and memory, in animal (g)and children(h) studies ...
Pepicelli O, Fedele E, Bonanno G, Raiteri M, Ajmone-Cat MA, Greco A, Levi G, Minghetti L. In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E2 extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. Journal of neurochemistry 2002;81(5):1028-1034 ...
Overproduction of VLDL-TG by the liver is a prominent sequel of insulin resistance, obesity, and diabetes1,2,32,33 and leads to dyslipidemia and cardiovascular disease.32,34 We here report, for the first time to our knowledge, that glycine lowers hepatic VLDL-TG secretion via the central nervous system (CNS). Glycine is the smallest nonessential amino acid and a coagonist of the NMDA receptor along with glutamate.29,30 NMDA receptors in the CNS are important for neurotransmission and have critical roles in mechanisms of synaptic plasticity and network synchronization.29 Our current study demonstrates that glycine-induced potentiation of NR1-containing NMDA receptors in the DVC is sufficient to trigger the hepatic vagus and lower VLDL-TG secretion in normal rats.. The NR1 subunit is an obligatory subunit that forms a functional NMDA receptor when combined with either NR2 or NR3 subunits.29 A typical NMDA receptor is a tetramer that most often consists of 2 glycine-binding NR1 subunits and 2 ...
Acute hypertension produced by methamphetamine (MA) is well known, mainly by the enhancement of catecholamine release from sympathetic terminals. However, the central pressor mechanism of the blood-brain-barrier-penetrating molecule remains unclear. We used radio-telemetry and femoral artery cannulation to monitor the mean arterial pressure (MAP) in conscious free-moving and urethane-anesthetized rats, respectively. Expression of Fos protein (Fos) and phosphorylation of N-methyl-D-aspartate receptor subunit GluN1 in the rostral ventrolateral medulla (RVLM) were detected using Western blot analysis. ELISA was carried out for detection of protein kinase C (PKC) activity in the RVLM. MA-induced glutamate release in the RVLM was assayed using in vivo microdialysis and HPLC. Systemic or intracerebroventricular (i.c.v.) administration of MA augments the MAP and increases Fos expression, PKC activity, and phosphorylated GluN1-ser 896 (pGluN1-ser 896) in the RVLM. However, direct microinjection of MA into the
Working on the idea that postsynaptic and presynaptic mechanisms of long-term potentiation (LTP) expression are not inherently mutually exclusive, we have looked for the existence and functionality of presynaptic mechanisms for augmenting transmitter release in hippocampal slices. Specifically, we asked if changes in glutamate release might contribute to the conversion of silent synapses that show N-methyl-D-aspartate (NMDA) responses but no detectable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) responses, to ones that exhibit both. Here, we review experiments where NMDA receptor responses provided a bioassay of cleft glutamate concentration, using opposition between peak [glu]cleft and a rapidly reversible antagonist, L-AP5. We discuss findings of a dramatic increase in peak [glu]cleft upon expression of pairing-induced LTP (Choi). We present simulations with a quantitative model of glutamatergic synaptic transmission that includes modulation of the presynaptic fusion pore, ...
NMDA receptors are calcium ion channels that function at the postsynaptic side of excitatory synapses in the central nervous system. NMDA receptors are thought to be tetrameric in structure, composed of two NR1 subunits and two NR2 subunits. It is established that the NMDA receptors function in synaptic plasticity is largely mediated by the NR2 intracellular C-terminal domain, which interacts directly and indirectly with numerous postsynaptic signalling molecules (Sprengel et al 98, Migaud et al 98, Husi et al 00). The purpose of this study was to address questions of evolutionary conservation of the NR2 C-terminal domain and structural properties. Ryan et als study provides two main insights. The first was based on comparisons of the length of the NR2 C-terminus between paralogues and across species. Through simple amino acid sequence alignments of NR2 orthologues it became clear that the NR2 C-terminus profoundly differs in size between vertebrates and invertebrates, with vertebrates ...
N-Methyl-D-aspartic acid or N-Methyl-D-aspartate (NMDA) is an amino acid derivative that acts as a specific agonist at the NMDA receptor mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor. Unlike glutamate, NMDA only binds to and regulates the NMDA receptor and has no effect on other glutamate receptors (such as those for AMPA and kainate). NMDA receptors are particularly important when they become overactive during withdrawal from alcohol as this causes symptoms such as agitation and, sometimes, epileptiform seizures. NMDA is a water-soluble synthetic substance that is not normally found in biological tissue. It was first synthesized in the 1960s. NMDA is an excitotoxin (it kills nerve cells by over-exciting them); this trait has applications in behavioral neuroscience research. The body of work utilizing this technique falls under the term lesion studies. Researchers apply NMDA to specific regions of an (animal) subjects brain or spinal cord and ...
Nitric oxide (NO) has long been implicated in the generation of long-term potentiation (LTP) and other types of synaptic plasticity, a role for which the intimate coupling between NMDA receptors (NMDARs) and the neuronal isoform of NO synthase is likely to be instrumental in many instances. While many types of synaptic plasticity depend on NMDA receptors, others do not, an example of which is LTP triggered by opening of L-type voltage-gated Ca2+ channels (L-VGCCs) in postsynaptic neurons. In CA3-CA1 synapses in the hippocampus, NMDAR-dependent LTP appears to be primarily expressed postsynaptically whereas L-VGCC-dependent LTP, which often coexists with NMDAR-dependent LTP, appears mainly to reflect enhanced presynaptic transmitter release. Since NO is an excellent candidate as a retrograde messenger mediating post-to-presynaptic signaling, we sought to determine if NO functions in L-VGCC-dependent LTP in mouse CA3-CA1 synapses. When elicited by a burst type of stimulation with NMDARs and the associated
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
TY - JOUR. T1 - Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine. AU - Mao, Li Min. AU - Wang, Wei. AU - Chu, Xiang Ping. AU - Zhang, Guo Chi. AU - Liu, Xian Yu. AU - Yang, Yuan Jian. AU - Haines, Michelle. AU - Papasian, Christopher J.. AU - Fibuch, Eugene E.. AU - Buch, Shilpa. AU - Chen, Jian Guo. AU - Wang, John Q.. PY - 2009/5/1. Y1 - 2009/5/1. N2 - Plastic changes in glutamatergic synapses that lead to endurance of drug craving and addiction are poorly understood. We examined the turnover and trafficking of NMDA receptors and found that chronic exposure to the psychostimulant amphetamine (AMPH) induced selective downregulation of NMDA receptor NR2B subunits in the confined surface membrane pool of rat striatal neurons at synaptic sites. This downregulation was a long-lived event and was a result of the destabilization of surface-expressed NR2B caused by accelerated ubiquitination and degradation of crucial NR2B-anchoring proteins by the ...
Drug discrimination studies in rats and monkeys with competitive N-methyl-D-aspartate (NMDA) antagonists an training drugs have shown that these drugs typically cross-substitute for each other, whereas phencyclidine (PCP)-like NMDA channel blockers produce partial, if any, substitution. In the present study, rats and squirrel monkeys were trained to discriminate the
Glutamate-induced delayed calcium dysregulation (DCD) is usually causally associated with excitotoxic neuronal death. Ro 25-6981, and Co 101244 inhibit NCXrev. The power of ifenprodil to inhibit NCXrev correlates using its effectiveness in avoiding DCD and stresses an important part of NCXrev in DCD. Overall our data claim that both NR2A- and NR2B-NMDARs get excited about DCD in old neurons, which is essential to inhibit both NMDARs and NCXrev to avoid glutamate-induced DCD. (Cull-Candy et al., 2001). Ifenprodil was discovered to become the 1st neuroprotective agent selective for NR2B-containing NMDARs (NR2B-NMDARs) (Carter et al., 1988; Carter et al., 1989; Williams, 1993). Significantly, ifenprodil escalates the strength of protons to stop the NMDAR (Mott et al., 1998) and protects neurons against glutamate excitotoxicity within an activity-dependent way (Kew et al., 1996). This system was suggested to significantly donate to ifenprodil effectiveness and having less negative effects of this ...
The NMDA subtype of ionotropic glutamate receptors has been implicated in the activity-dependent modification of synaptic efficacy in the mammalian brain. Here we describe a cDNA isolated from Drosophila melanogaster which encodes a putative invertebrate NMDA receptor protein (DNMDAR-I). The deduced …
A series of 2-substituted 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides were synthesized and evaluated for their affinity to the glycine binding site of the N-methyl-d-aspartate (NMDA) receptor. The binding affinity was determined by the displacement of radioligand [(3)H]MDL-105,519 from rat cortical membrane preparations. The most attractive structures in the search for prospective NMDA receptor ligands were identified to be 2-arylcarbonylmethyl substituted 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides. It has been demonstrated for the first time that the replacement of NH group in the ligand by sp(3) CH2 is tolerated. This finding may pave the way for previously unexplored approaches for designing new ligands of the NMDA receptor.
A budget friendly reagent kit from Alomone Labs. Contains a specific NMDA Receptor 2B antibody & biologically active NR2B agonists & antagonists. Lyophilized powder. Economical. Worldwide shipping at room temperature. Your top supplier for glutamate receptor research!
Kleckner NW, Glazewski JC, Chen CC, Moscrip TD (May 1999). "Subtype-Selective Antagonism of N-Methyl-D-aspartate Receptors by ... Harty TP, Rogawski MA (March 2000). "Felbamate Block of Recombinant N-Methyl-D-aspartate Receptors: Selectivity for the NR2B ... Opposing Effects on N-Methyl-D-aspartate and Gamma-Aminobutyric Acid A Receptors". Annals of Neurology. 35 (2): 229-34. doi: ... "Felbamate Block of the N-Methyl-D-aspartate Receptor". The Journal of Pharmacology and Experimental Therapeutics. 273 (2): 878- ...
Schizophrenia: N-methyl-D-aspartate Receptor Dysfunction and Cortical Connectivity. 68 (1): 61-69. doi:10.1016/j.biopsych. ...
December 2012). "N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis". Annals of Neurology. 72 (6): 902-911 ... November 2016). "N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis". ... Herpesviral encephalitis can serve as a trigger of anti-NMDA receptor encephalitis. About 30% of HSE patients develop this ... November 2019). "An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models". The ...
N-methyl-D-aspartate receptor antagonist desegregates eye-specific stripes. Cline HT, Debski EA, Constantine-Paton M. Proc Natl ... Using this system, she and her colleagues demonstrated the importance of NMDA receptors in development plasticity. She ...
Several receptors directly interact with ethanol to promote a cascade of signaling. N-methyl-D-aspartate (NMDA) receptors are ... Ethanol sensitivity of recombinant human N-methyl-D-aspartate receptors. Neurochem Int. 38, 333-340. Nagy, J. (2004). The NR2B ... Another family of receptors, metabotropic glutamate receptors (mGluR), may also contribute by activating MAPK pathways and ... In chronic ethanol users, ethanol binds to GABA receptors causing the down-regulation of GABA receptors; which are now less ...
Lau LF, Huganir RL (1995). "Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits". J Biol Chem. 270 ... The major excitatory neurotransmitter receptors in the central nervous system are the glutamate receptors. These receptors can ... association of growth factor with receptor dimerization of receptor and autophosphorylation of receptor tyrosine kinase (RTK) ... Receptor tyrosine kinases are type I transmembrane proteins possessing an N-terminal extracellular domain, which can bind ...
1998). "HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors ... "Entrez Gene: GRIN3B glutamate receptor, ionotropic, N-methyl-D-aspartate 3B". Schröder HC, Perovic S, Kavsan V, et al. (1998 ... 1999). "Evidence of HIV type 1 glycoprotein 120 binding to recombinant N-methyl-D-aspartate receptor subunits expressed in a ... 1995). "Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes ...
The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and ion channel found in ... Activation of NMDA receptors requires binding of glutamate or aspartate (aspartate does not stimulate the receptors as strongly ... The NMDA receptor is so named because the agonist molecule N-methyl-D-aspartate (NMDA) binds selectively to it, and not to ... Nadler V, Mechoulam R, Sokolovsky M (September 1993). "Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion ...
N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved ... "Entrez Gene: GRIN2D glutamate receptor, ionotropic, N-methyl D-aspartate 2D". Kurschner C, Yuzaki M (Sep 1999). "Neuronal ... Pittaluga A, Pattarini R, Severi P, Raiteri M (1996). "Human brain N-methyl-D-aspartate receptors regulating noradrenaline ... "HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a ...
"Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors". Neuron. 21 (2): 443-53. doi:10.1016/ ... "Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors". The ... "Competitive binding of alpha-actinin and calmodulin to the NMDA receptor". Nature. 385 (6615): 439-42. doi:10.1038/385439a0. ... "Competitive binding of alpha-actinin and calmodulin to the NMDA receptor". Nature. 385 (6615): 439-42. doi:10.1038/385439a0. ...
N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved ... "Entrez Gene: GRIN2C glutamate receptor, ionotropic, N-methyl D-aspartate 2C". Lim IA, Hall DD, Hell JW (Jun 2002). "Selectivity ... Pittaluga A, Pattarini R, Severi P, Raiteri M (1996). "Human brain N-methyl-D-aspartate receptors regulating noradrenaline ... "The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression". ...
"A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in ... "Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia". Molecular Psychiatry. 18 (11): 1185-92. doi ... "Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and ... In particular, the expression of mRNA for the NR1 receptor subunit, as well as the protein itself is reduced in the prefrontal ...
"Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites". Organic Letters. 19 (17): 4572-4575. doi: ... support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists". Arch Gen Psychiatry. 57 (3): 270-6. doi: ... "Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors". Anesthesiology. 86 (4): 903-17. doi:10.1097/ ... of NMDA receptors in the brain results in an activation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA ...
This gene encodes a subunit of the N-methyl-D-aspartate (NMDAR) receptors, which belong to the superfamily of glutamate- ... "Entrez Gene: GRIN3A glutamate receptor, ionotropic, N-methyl-D-aspartate 3A". Schröder HC, Perovic S, Kavsan V, Ushijima H, ... Pittaluga A, Pattarini R, Severi P, Raiteri M (1996). "Human brain N-methyl-D-aspartate receptors regulating noradrenaline ... "HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a ...
The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor ... "Entrez Gene: GRIN1 glutamate receptor, ionotropic, N-methyl D-aspartate 1". Sengar AS, Li H, Zhang W, Leung C, Ramani AK, Saw ... Pittaluga A, Pattarini R, Severi P, Raiteri M (May 1996). "Human brain N-methyl-D-aspartate receptors regulating noradrenaline ... "N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes". ...
... hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors". J. Neurosci. 33 (44): 17290-300. doi: ... "Different oxysterols have opposing actions at N-methyl-D-aspartate receptors". Neuropharmacology. 85: 232-42. doi:10.1016/j. ... GABAA receptor positive allosteric modulator SGE-516 - GABAA receptor positive allosteric modulator SGE-872 - GABAA receptor ... GABAA receptor negative allosteric modulator, NMDA receptor positive allosteric modulator, sigma-1 receptor agonist, TRPM3 ...
The underlying mechanism is autoimmune with the primary target the GluN1 subunit of the N-methyl D-aspartate receptors (NMDAR) ... Sébire, Guillaume (2010-02-23). "In search of lost time from "Demonic Possession" to anti-N-methyl-D-aspartate receptor ... "Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents". Annals of Neurology. 66 (1): 11-8. doi: ... "Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma". Annals of Neurology. 61 (1): ...
"Entrez Gene: GRINL1A glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A". Maruyama K, Sugano S (1994). "Oligo-capping ... NMDA receptor GRCh38: Ensembl release 89: ENSG00000255529 - Ensembl, May 2017 GRCm38: Ensembl release 89: ENSMUSG00000032199 - ... Roginski RS, Mohan Raj BK, Finkernagel SW, Sciorra LJ (2001). "Assignment of an ionotropic glutamate receptor-like gene ( ... Ionotropic glutamate receptors, All stub articles, Human chromosome 4 gene stubs). ...
Sun S, Wallach J, Adejare A (2014). "Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated ... and μ-opioid receptor agonistic properties. Additionally, σ receptor agonistic, nACh receptor antagonistic, and D2 receptor ... Structure activity relationship (SAR) studies of arylcycloalkylamines as N-methyl-D-aspartate receptor antagonists. PhD. Thesis ... For instance, 4-methyl-PCP, 4'-methyl-PCP and 4''-methyl-PCP are all known compounds, with similar activity but quite different ...
Mathiesen O, Imbimbo BP, Hilsted KL, Fabbri L, Dahl JB (August 2006). "CHF3381, a N-methyl-D-aspartate receptor antagonist and ... August 2003). "Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride ... a putative N-methyl-D-aspartate receptor antagonist". NeuroReport. 13 (16): 2071-4. doi:10.1097/00001756-200211150-00016. PMID ... non-competitive NMDA receptor antagonist. A pilot study of indantadol for chronic cough was initiated in October 2009 and in ...
January 2007). "Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma". Annals of ... anti-NMDA receptor encephalitis, and polymyositis. The following diseases manifest by means of mucocutaneous dysfunction: ...
"Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker". Proceedings of the National Academy of ... Unlike other cannabinoid derivatives, HU-211 does not act as a cannabinoid receptor agonist, but instead has NMDA antagonist ... NMDA receptor antagonists, Phenols, Benzochromenes, Primary alcohols, HU cannabinoids). ...
N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. The NMDA receptor channel has been shown ... Glutamate [NMDA] receptor subunit epsilon-2, also known as N-methyl D-aspartate receptor subtype 2B (NMDAR2B or NR2B), is a ... "Entrez Gene: GRIN2B glutamate receptor, ionotropic, N-methyl D-aspartate 2B". Yoshimura Y, Ohmura T, Komatsu Y (July 2003). " ... Adams SL, Foldes RL, Kamboj RK (January 1995). "Human N-methyl-D-aspartate receptor modulatory subunit hNR3: cloning and ...
N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved ... "Entrez Gene: GRIN2A glutamate receptor, ionotropic, N-methyl D-aspartate 2A". Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, ... Ma J, Zhang GY (September 2003). "Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its ... Foldes RL, Adams SL, Fantaske RP, Kamboj RK (August 1994). "Human N-methyl-D-aspartate receptor modulatory subunit hNR2A: ...
Brandt MR, Cummons TA, Potestio L, Sukoff SJ, Rosenzweig-Lipson S (June 2005). "Effects of the N-methyl-D-aspartate receptor ... August 2004). "Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0] ... a potent N-methyl-D-aspartate antagonist, via the use of 3-cyclobutene-1,2-dione as an achiral alpha-amino acid bioisostere". ... NMDA receptor antagonists, Phosphonic acids, Quinones, Cyclobutenes, Nitrogen heterocycles, Heterocyclic compounds with 2 rings ...
Lerma J, Martín del Río R (February 1992). "Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex ... GABAA receptor positive allosteric modulators, NMDA receptor antagonists, Aromatic acids, Chloride channel blockers, All stub ... Sinkkonen ST, Mansikkamäki S, Möykkynen T, Lüddens H, Uusi-Oukari M, Korpi ER (September 2003). "Receptor subtype-dependent ... positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug". ...
Woo TU, Shrestha K, Lamb D, Minns MM, Benes FM (April 2008). "N-Methyl-D-Aspartate Receptor and Calbindin-Containing Neurons in ... Suchanek B, Seeburg PH, Sprengel R (January 1995). "Gene structure of the murine N-methyl D-aspartate receptor subunit NR2C". J ... NMDA receptors rely on the EPSC produced by AMPA receptors to open. NMDA receptors are permeable to Ca2+, which is an important ... Johnson JW, Ascher P (May 1990). "Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels". ...
Chen BS, Braud S, Badger JD, Isaac JT, Roche KW (June 2006). "Regulation of NR1/NR2C N-methyl-D-aspartate (NMDA) receptors by ... The main receptors associated with PSD-95 are NMDA receptors. The first two PDZ domains of PSD-95 bind to the C-terminus of ... Glutamate receptor interacting protein (GRIP) is a post-synaptic protein that interacts with AMPA receptors in a fashion ... When researchers noticed apparent structural homology between the C-termini of AMPA receptors and NMDA receptors, they ...
Hirbec H, Gaviria M, Vignon J (2001). "Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor". ... With the use of this drug, motor skills have significantly improved upon use, as it is the antagonist to the NMDA receptor. ... is a psychoactive drug which acts as a dissociative via functioning as a non-competitive NMDA receptor antagonist. It is ... "The search for TCP analogues binding to the low affinity PCP receptor sites in the rat cerebellum". European Journal of ...
... a positive allosteric modulator at the N-methyl-D-aspartate receptor". Molecular Pharmacology. 40 (3): 333-6. PMID 1654510. ... CB1 receptor antagonists, Glycine receptor agonists, Ketones, Neurosteroids, Pregnane X receptor agonists, Pregnanes, Sigma ... December 2008). "Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells". Nature ... It prevents CB1 receptor agonists like tetrahydrocannabinol, the main active constituent in cannabis, from fully activating the ...
Ripellino JA, Neve RL, Howe JR (1998). "Expression and heteromeric interactions of non-N-methyl-D-aspartate glutamate receptor ... "Expression and heteromeric interactions of non-N-methyl-D-aspartate glutamate receptor subunits in the developing and adult ... 2003). "Heteromer formation of delta2 glutamate receptors with AMPA or kainate receptors". Brain Res. Mol. Brain Res. 110 (1): ... Glutamate receptor, ionotropic kainate 5 is a protein that in humans is encoded by the GRIK5 gene. This gene encodes a protein ...
... showing the increased activity of N-methyl-D-aspartate receptors. This plays a role in consciousness and learning resulting in ... Gamma-aminobutyric acid receptor subunit alpha-4 is a protein that in humans is encoded by the GABRA4 gene. GABA is the major ... Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At ... Mu W, Cheng Q, Yang J, Burt DR (2002). "Alternative splicing of the GABA(A) receptor alpha 4 subunit creates a severely ...
"Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current". Mol. Pharmacol. 59 (5): 960 ... phosphorylation site for calcium/calmodulindependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor ...
... other receptors. For example, group I mGluRs are known to increase the activity of N-methyl-D-aspartate receptors (NMDARs), a ... "Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and ... the receptor most involved in that process. Excessive amounts of N-methyl-D-aspartate (NMDA), the selective specific agonist of ... "Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity". European Journal of ...
... also examined how mild exercise affected androgen synthesis which in turn causes AHN activation of N-methyl-D-aspartate (NMDA) ... Also, androgens, but not estrogens, increase beta adrenergic receptors while decreasing alpha adrenergic receptors- which ... Zuloaga DG, Puts DA, Jordan CL, Breedlove SM (May 2008). "The role of androgen receptors in the masculinization of brain and ... Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S (October 2004). "Androgen receptor in human skeletal muscle ...
Postpartum anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review. Internal Medicine 56: 357-362 ... Ito Y, Abe T, Tomioka R, Komori T, Araki N (2010) [Anti-NMDA receptor encephalitis during pregnancy]. Rinsho Shinkeigaku 50: ... recent form of organic childbearing psychosis to be described is encephalitis associated with antibodies to the NMDA receptor; ... steroid hormone-dependent regulation of neuronal calcium influx via extracellular matrix proteins and membrane receptors ...
... a positive allosteric modulator at the N-methyl-D-aspartate receptor" (abstract). Molecular Pharmacology. 40 (3): 333-6. PMID ... The GABAA receptors are made up of subunits which form a receptor complex. Humans have 19 receptor subunits and are classified ... Neurosteroids can act as allosteric modulators of neurotransmitter receptors, such as the GABAA, NMDA, and sigma receptors. The ... "Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABAA receptors using artificial neural ...
... danger and is likely caused by an overactivation of N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4- ... The depolarization and calcium overload experienced by overactive receptors signal the expression of cell death pathways. ... isoxazolepropionic acid (AMPA) receptors by the surplus signaling of excitatory neurotransmitters. ...
Glutamate receptor, ionotropic, N-methyl D-aspartate-like 1B, also known as GRINL1B, is a human gene. The protein encoded by ... Mohan Raj BK, Roginski RS, Finkernagel SW, Sciorra LJ (2001). "Assignment of GRINL1B, a glutamate receptor-like processed gene ... Ionotropic glutamate receptors, All stub articles, Membrane protein stubs). ... this gene is a subunit of the NMDA receptor. ...
N-methyl-D-aspartate receptor - N-methylaspartate - N-terminus - NADH - NADPH - NaKATPase - native state - nef gene product - ... interleukin receptor - interleukin-1 receptor - interleukin-2 receptor - interleukin-3 - interleukin-3 receptor - intermediate ... G protein-coupled receptor - G3P - GABA - GABA receptor - GABA-A receptor - gag-onc fusion protein - galanin - gamete - gamma- ... IgE receptor - IGF type 1 receptor - IGF type 2 receptor - IgG - IgM - immediate-early protein - immune cell - immune system - ...
Schäbitz WR, Li F, Fisher M (July 2000). "The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter ... N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist". Journal of ... N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist". Journal of ...
2014). "Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: A ... "Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: A ... Estrogen seems to have a dampening effect on dopamine receptors. Evidence suggests that it is the interaction between genes and ... Silvestri S, Negrete JC, Seeman MV, Shammi CM, Seeman P (April 2004). "Does nicotine affect D2 receptor upregulation? A case- ...
However, brain-derived neurotrophic factor (BDNF) and the N-methyl-D-aspartate receptors (NMDA) have been identified as crucial ... DNA methylation is a process by which methyl groups attach to DNA structure causing the gene to not be expressed. This is ... and various DNA Methyl-Transferases (DNMTs), and increased presence of miRNAs for transcription factors and VEGF. It is ...
Kim, Jeansok J.; Decola, Joseph P.; Landeira-Fernandez, Jesus; Fanselow, Michael S. (1991). "N-methyl-D-aspartate receptor ... Synthetic ligand injection - A receptor activated solely by a synthetic ligand (RASSL) or Designer Receptor Exclusively ... These systems utilize G protein-coupled receptors (GPCR) engineered to respond exclusively to synthetic small molecules ligands ... Ferguson, Susan (2012). "Grateful DREADDs: Engineered Receptors Reveal How Neural Circuits Regulate Behavior". ...
Xie, H Y; Clarke, S (1994). "Protein phosphatase-2A is reversibly modified by methyl esterification at its C-terminal leucine ... identifying membrane receptors for bacterial chemotaxis. Clarke's research at UCLA has focused on roles of novel protein ... D-aspartate) O-methyltransferase". J. Biol. Chem. 269 (40): 24586-24595. doi:10.1016/S0021-9258(17)31432-1. PMID 7929130. ...
The synaptic changes depend on a special type of glutamate receptor, the N-methyl-D-aspartate (NMDA) receptor, a cell surface ... Drugs that interfere with NMDA receptors block LTP and have major effects on some types of memory, especially spatial memory. ... The hippocampus contains high levels of glucocorticoid receptors, which make it more vulnerable to long-term stress than most ... Furthermore, many other genes were upregulated, likely often due to the removal of methyl groups from previously existing 5- ...
"Chronic intermittent ethanol treatment selectively alters N-methyl-D-aspartate receptor subunit surface expression in cultured ... Ethanol inhibits the ability of glutamate to open the cation channel associated with the N-methyl-D-aspartate (NMDA) subtype of ... Alteration of NMDA receptor numbers in chronic alcoholics is likely to be responsible for some of the symptoms seen in delirium ... NMDA receptors become unresponsive, slowing areas of the brain for which they are responsible. Contributing to this effect is ...
"Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor anatagonist, AP5". ... The function of NMDA receptors varies according to the subregion of the hippocampus. NMDA receptors are required in the CA3 of ... Spatial learning requires both NMDA and AMPA receptors, consolidation requires NMDA receptors, and the retrieval of spatial ... Blockade of the NMDA receptors prevents induction of long-term potentiation and impairs spatial learning. The CA3 of the ...
"Expression and heteromeric interactions of non-N-methyl-D-aspartate glutamate receptor subunits in the developing and adult ... This includes 5 subunits of the glutamate receptor ionotropic AMPA glutamate receptor subunits (Glur2, Glur3, Glur4) and ... "Protein kinase C gamma associates directly with the GluR4 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor ... "Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor channels lacking the N-terminal domain". The Journal ...
"Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist ... D-serine acts as a neuronal signaling molecule by activating NMDA receptors in the brain. Since NMDA receptors Dysfunction has ... Serine racemase may have evolved from L-thre-hydroxyaspartate (L-THA) eliminase and served as the precursor to aspartate ...
Likewise, SP is known to bind to N-methyl-D-aspartate (NMDA) receptors by eliciting excitation with calcium ion influx, which ... The tachykinin receptor 1 (TACR1) also known as neurokinin 1 receptor (NK1R) or substance P receptor (SPR) is a G protein ... SP binds to all three of the tachykinin receptors, but it binds most strongly to the NK1 receptor. Tachykinin NK1 receptor ... NK1 receptor, as well as the other tachykinin receptors, is made of seven hydrophobic transmembrane (TM) domains with three ...
... a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic ... "Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors". Proceedings of the ... an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors". Experimental Neurology. 163 (1): 239-43. doi:10.1006/ ... a potent new neuroprotectant which blocks N-methyl-D-aspartate responses". Journal of Medicinal Chemistry. 38 (16): 3138-45. ...
... and N-methyl-D-aspartate). Inhibitory effects on 5-HT, norepinephrine, and dopamine transporters are weak. Lamotrigine is a ... It antagonises these receptors with the following IC50 values: 5-HT3, IC50 = 18 μM σ receptors, IC50 = 145 μM The ... It also blocks L-, N-, and P-type calcium channels and weakly inhibits the serotonin 5-HT3 receptor. These actions are thought ... Braga MF, Aroniadou-Anderjaska V, Post RM, Li H (March 2002). "Lamotrigine reduces spontaneous and evoked GABAA receptor- ...
One way they do this is by targeting the N-methyl-D-aspartate receptor (NMDAR), which has a vital role in transmission of ...
"Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor ... In addition, the drugs were tested on recombinant AMPA receptors and showed no potentiation of the receptors, indicating that ... Sunifiram, as well as unifiram, were assayed at a wide panel of sites, including the most important receptors, ion channels, ... However, they were able to prevent the amnesia induced by the AMPA receptor antagonist NBQX in the passive avoidance test, ...
Tikka TM, Koistinaho JE (June 2001). "Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by ... Over-excitation of glutamate receptors, specifically NMDA receptors, allows for an increase in calcium ion (Ca2+) influx due to ... 17β-Estradiol helps regulate excitotoxicity by inhibiting NMDA receptors as well as other glutamate receptors. Ginsenoside Rd: ... protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors ...
Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Download Prime PubMed App ... polyamines at N-methyl-D-aspartate receptors.. *An aspartate residue in the extracellular loop of the N-methyl-D-aspartate ... AnimalsDose-Response Relationship, DrugN-MethylaspartatePeptide FragmentsReceptors, N-Methyl-D-AspartateRecombinant Proteins ... Williams K. Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Mol Pharmacol ...
Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.. V I Ilyin, E R Whittemore, J Guastella, E Weber ... Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.. V I Ilyin, E R Whittemore, J Guastella, E Weber ... Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.. V I Ilyin, E R Whittemore, J Guastella, E Weber ... Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Message Subject (Your Name) has forwarded a page ...
Systemic Nicotine Stimulates Dopamine Release in Nucleus Accumbens: Re-evaluation of the Role ofN-Methyl-d-aspartate Receptors ... Systemic Nicotine Stimulates Dopamine Release in Nucleus Accumbens: Re-evaluation of the Role ofN-Methyl-d-aspartate Receptors ... Systemic Nicotine Stimulates Dopamine Release in Nucleus Accumbens: Re-evaluation of the Role ofN-Methyl-d-aspartate Receptors ... Systemic Nicotine Stimulates Dopamine Release in Nucleus Accumbens: Re-evaluation of the Role ofN-Methyl-d-aspartate Receptors ...
... receptor antibody encephalitis is becoming an increasingly recognized cause of encephalopathy in cases previously presumed to ... BACKGROUND: Anti-N-methyl-d-aspartate (NMDA) receptor antibody encephalitis is becoming an increasingly recognized cause of ... Three Phenotypes of Anti-N-Methyl-d-Aspartate Receptor Antibody Encephalitis in Children: Prevalence of Symptoms and Prognosis ... DeSena AD, Greenberg BM, Graves D (2014) Three Phenotypes of Anti-N-Methyl-d-Aspartate Receptor Antibody Encephalitis in ...
An open-label pilot study of memantine, an N-methyl-D-aspartate receptor antagonist in chronic cough. Rayid Abdulqwai, Rachel ... Background: N-Methyl-D-Aspartate Receptor (NMDAR) mediated central sensitisation of the cough reflex may play a role in chronic ... An open-label pilot study of memantine, an N-methyl-D-aspartate receptor antagonist in chronic cough ... An open-label pilot study of memantine, an N-methyl-D-aspartate receptor antagonist in chronic cough ...
Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics.. ... Circulating autoantibodies directed against extracellular domains of the glutamatergic N-methyl-D-aspartate receptors (NMDAR-Ab ... Since NMDAR and dopamine D1 receptors (D1R) form membrane signaling complexes, we investigated whether NMDAR-Ab purified from ...
... untranslated region of the N-methyl-D-aspartate receptor NR2A subunit controls efficiency of translation. ... The N-methyl-D-aspartate (NMDA) receptor plays a central role in such phenomena as long term potentiation and excitotoxicity. ... The 5-untranslated region of the N-methyl-D-aspartate receptor NR2A subunit controls efficiency of translation. Journal ... Whereas the NR1 subunit of the NMDA receptor is ubiquitously transcribed throughout the brain, transcription of NR2 subunits is ...
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a common type of autoimmune encephalitis. Patients with this ... Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a common type of autoimmune encephalitis. Patients with this ... Anti-N-methyl-D-aspartate receptor encephalitis: characteristics and rapid diagnostic approach in the emergency department. * ... Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a common type of autoimmune encephalitis, where pathogenic ...
N-methyl-D-aspartate receptors (NMDAR) are ionotropic glutamate receptors which can be blocked by Mg2+ in a voltage-dependent ... Methyl aspartate receptors, Alzheimers disease, NMDAR blocker, Neuroprotection. Subjects:. Q Science , QP Physiology , QP351 ... Abu, Izuddin Fahmy (2016) Exploring block and permeation of N-methyl-D-Aspartate (NMDA) receptor channels for treatment of ... Exploring block and permeation of N-methyl-D-Aspartate (NMDA) receptor channels for treatment of neurodegenerative disorders ...
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a neuropsychiatric disease characterized by an antibody-mediated ... Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor.. Le 27 Oct 2021 ... Publications , Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor. ... Here, we immunized mice against the region of NMDA receptor containing the N368/G369 amino acids, previously implicated in a ...
Paroxysmal EEG pattern in a child with N-methyl-d-aspartate receptor antibody encephalitis ... Paroxysmal EEG pattern in a child with N-methyl-d-aspartate receptor antibody encephalitis ...
N-methyl-D-aspartate (NMDA) receptor: friend or foe? Indian Journal of Experimental Biology. 1998 Oct; 36(10): 947-59. ...
N-Methyl-D-Aspartate" by people in this website by year, and whether "Receptors, N-Methyl-D-Aspartate" was a major or minor ... Receptors, Ionotropic Glutamate [D12.776.543.750.720.200.450.400]. *Receptors, N-Methyl-D-Aspartate [D12.776.543.750.720.200. ... Receptors, Ionotropic Glutamate [D12.776.157.530.400.400.500]. *Receptors, N-Methyl-D-Aspartate [D12.776.157.530.400.400. ... Receptors, Ionotropic Glutamate [D12.776.543.550.425.500.200]. *Receptors, N-Methyl-D-Aspartate [D12.776.543.550.425.500. ...
Chartoff, E. H., Ward, R. P., & Dorsa, D. M. (1999). Role of adenosine and N-methyl-D-aspartate receptors in mediating ... Chartoff, Elena H. ; Ward, Raymond P. ; Dorsa, Daniel M. / Role of adenosine and N-methyl-D-aspartate receptors in mediating ... Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. Journal of ... Dive into the research topics of Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene ...
N-methyl-D-aspartate (NMDA) receptor antagonists. * St. Johns wort (Hypericum perforatum) ... The HTR3A and HTR3B regions, which encode serotonin receptors and are located at chromosome 11q23.2, are also known to be ... Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet ... All this, together with preclinical research findings, implies a role for neuronal receptor regulation, intracellular signaling ...
glutamate receptor subunit epsilon-2. *glutamate receptor, ionotropic, N-methyl D-aspartate 2B ... NMDA receptors are glutamate-gated ion channels. When brain chemicals called glutamate and glycine attach to the receptor, a ... A shortage of this protein may reduce the number of functional NMDA receptors, which would reduce receptor activity in cells. ... Researchers are unsure how abnormal activity of NMDA receptors prevents normal growth and development of the brain or why too ...
A key recent development was the discovery of antibodies to NMDA receptors in some cases of encephalitis, characterized by ... Here we describe a unique de novo autoimmune mouse model of anti-NMDA receptor encephalitis. Active immunization of immune ... competent mice with conformationally-stabilized, native-like NMDA receptors induced a fulminant encephalitis with behavioral ...
... Published November 18, 2014 , By admin ... Anti-N-methyl D-aspartate receptor (NMDAR) encephalitis is a severe neuropsychiatric disorder that associates with prominent ... N-methyl D-aspartate receptor antibodies, NMDA, research ...
There are now a large number of requests for N-methyl-D-aspartate receptor autoantibody (NMDAR-Ab) tests, and it is important ... OBJECTIVE: There are now a large number of requests for N-methyl-D-aspartate receptor autoantibody (NMDAR-Ab) tests, and it is ... Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. ... IMMUNOLOGY, NEUROIMMUNOLOGY, NMDA, PARANEOPLASTIC SYNDROME, PSYCHIATRY, Adolescent, Adult, Anti-N-Methyl-D-Aspartate Receptor ...
A series of short chain alkanols were studied for their effects on N-methyl-D-aspartate (NMDA)-evoked release [3H] ... Receptors, N-Methyl-D-Aspartate / drug effects * Receptors, N-Methyl-D-Aspartate / metabolism* ... Alcohol-induced inhibition of N-methyl-D-aspartate-evoked release of [3H]norepinephrine from brain is related to lipophilicity ... A series of short chain alkanols were studied for their effects on N-methyl-D-aspartate (NMDA)-evoked release [3H] ...
N-methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. / Hwang, Jee Yeon; Kim, Yang Hee; Ahn, ... N-methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Experimental Neurology. 1999 Sep;159(1): ... N-methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. In: Experimental Neurology. 1999 ; Vol. ... Hwang, J. Y., Kim, Y. H., Ahn, Y. H., Wie, M. B., & Koh, J. Y. (1999). N-methyl-D-aspartate receptor blockade induces neuronal ...
N-methyl-D-aspartate receptors are indispensable for the formation of long-term potentiation in the rat suprachiasmatic nucleus ... Dive into the research topics of N-methyl-D-aspartate receptors are indispensable for the formation of long-term potentiation ...
N-methyl-D-aspartate receptor (NMDAR) hypofunction is hypothesised to underlie psychosis but this has not been tested early in ... N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study ... N-methyl-D-aspartate receptor (NMDAR) hypofunction is hypothesised to underlie psychosis but this has not been tested early in ... N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study ...
Anesthetic Care for a Pediatric Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis ... First characterized in 2007, anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder with the ... Anesthetic Care for a Pediatric Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis. ... We describe the anesthetic management of a patient with anti-NMDA receptor encephalitis who required anesthetic care during ...
... anesthetics nitrous oxide and xenon are reported to have little effect on GABAA receptors but inhibit N-methyl-d-aspartate ( ... NMDA receptors were the most sensitive among glutamate receptors and were inhibited by nitrous oxide by 31%. 5-HT3 receptors ... MethodsThe glycine, GABAA, GABA receptor type C (GABAC), NMDA, &agr;-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA ... The sensitivity was different between &agr;4&bgr;2 and &agr;4&bgr;4 nACh receptors; &agr;4&bgr;2 receptors were inhibited by ...
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies ...
Recent findings of N-methyl d-aspartate (NMDA) antibodies in autoimmune encephalitis suggested that it caused symptoms like ... group were positive for serum anti-NMDA receptor antibodies (> 200 pg/ml, p = 0.0157). The positive anti-NMDAR antibody was ... From: N-Methyl-d-aspartate (NMDA) receptor antibody in relation to autism spectrum disorder (ASD): presence and association ...
Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2 −/− Mice ... Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2 −/− Mice In ... Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2 −/− Mice . ... Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2 −/− Mice ...
  • Stimulatory effects of spermine at heteromeric N-methyl-D-aspartate (NMDA) receptors expressed from cloned subunits were studied by voltage-clamp recording in Xenopus oocytes. (unboundmedicine.com)
  • At NR1A/NR2B receptors, in the presence of a saturating concentration of glycine, the magnitude of spermine stimulation was dependent on the concentration of NMDA or glutamate. (unboundmedicine.com)
  • Spermine induced a small (1.2-1.5-fold) decrease in the affinity of NR1A/NR2B receptors for NMDA and glutamate. (unboundmedicine.com)
  • Spermine did not alter the affinity of NR1A/NR2A receptors for NMDA. (unboundmedicine.com)
  • Endogenous polyamines could act as a bidirectional gain control at some native NMDA receptors containing the NR1A and NR2B subunits, by dampening the response to low concentrations of glutamate and enhancing the response to high concentrations of glutamate. (unboundmedicine.com)
  • Alternatively, polyamines could enhance the decay of NMDA receptor-mediated responses by increasing the rate of dissociation of glutamate from the receptor. (unboundmedicine.com)
  • A1 - Williams,K, PY - 1994/7/1/pubmed PY - 1994/7/1/medline PY - 1994/7/1/entrez SP - 161 EP - 8 JF - Molecular pharmacology JO - Mol Pharmacol VL - 46 IS - 1 N2 - Stimulatory effects of spermine at heteromeric N-methyl-D-aspartate (NMDA) receptors expressed from cloned subunits were studied by voltage-clamp recording in Xenopus oocytes. (unboundmedicine.com)
  • BACKGROUND: Anti-N-methyl-d-aspartate (NMDA) receptor antibody encephalitis is becoming an increasingly recognized cause of encephalopathy in cases previously presumed to be viral encephalitis. (icnapedia.org)
  • To find comparable articles reflecting this classification, we then performed a MEDLINE search of all articles involving the subject heading "anti-NMDA receptor encephalitis" or just the keyword phrase "NMDA encephalitis," and we found 162 articles to review. (icnapedia.org)
  • We note that the poorest responders, even to aggressive immunotherapies, are the patients with catatonia-persistent type anti-NMDA receptor antibody encephalitis, which has, as its hallmark, prolonged periods of severe encephalopathy. (icnapedia.org)
  • Patients with predominantly psychiatric symptoms, which we call the psychiatric-predominant anti-NMDA receptor antibody encephalitis, have had excellent responses to plasma exchange or other immunotherapies and appear to have the least residual deficits at follow-up. (icnapedia.org)
  • In our case series, we discuss representative examples of these clinical subtypes and their associated outcomes, and we suggest that tracking these subtypes in future cases of anti-NMDA receptor antibody encephalitis might lead to better understanding and better risk stratification with regard to immunotherapy decisions. (icnapedia.org)
  • The N-methyl-D-aspartate (NMDA) receptor plays a central role in such phenomena as long term potentiation and excitotoxicity. (duke.edu)
  • This importance in defining both function and viability suggests that neurons must carefully control their expression of NMDA receptors. (duke.edu)
  • Whereas the NR1 subunit of the NMDA receptor is ubiquitously transcribed throughout the brain, transcription of NR2 subunits is spatially and temporally controlled. (duke.edu)
  • Since heteromeric assembly of both subunits is required for efficient functional expression, post-transcriptional modification of either subunit would affect NMDA receptor activity. (duke.edu)
  • Taken together, these findings suggest a mechanism for modulation of NMDA receptor activity through the control of translational efficiency of a single subunit. (duke.edu)
  • Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a common type of autoimmune encephalitis, where pathogenic autoantibodies are directed against the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor. (biomedcentral.com)
  • NMDA receptors are found in the hippocampus of the human brain, where they are involved in learning and memory [ 1 ]. (biomedcentral.com)
  • Here, we immunized mice against the region of NMDA receptor containing the N368/G369 amino acids, previously implicated in a pathogenic response. (bb-c.fr)
  • IMSEAR at SEARO: N-methyl-D-aspartate (NMDA) receptor: friend or foe? (who.int)
  • NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. (childrensmercy.org)
  • Dysfunctions in mice by NMDA receptor point mutations NR1(N598Q) and NR1(N598R). (childrensmercy.org)
  • We hypothesize that both striatal gene induction and catalepsy elicited by haloperidol arise from the combined effect of excitatory adenosinergic and glutamatergic inputs acting at adenosine A(2A) and N-methyl-D-aspartate (NMDA) receptors, respectively. (elsevier.com)
  • In agreement with other reports, the noncompetitive NMDA receptor antagonist MK-801 also reduced gene expression and catalepsy in response to haloperidol. (elsevier.com)
  • The competitive NMDA receptor antagonist LY235959 decreased haloperidol-induced catalepsy. (elsevier.com)
  • We show here that blocking both A(2A) and NMDA receptors simultaneously in conjunction with haloperidol resulted in a combined effect on gene expression and behavior that was greater than that for block of either receptor alone. (elsevier.com)
  • These results indicate that the haloperidol-induced increases in c-fos and NT gene expression in the dorsolateral striatum and catalepsy are driven largely by adenosine and glutamatergic inputs acting at A(2A) and NMDA receptors. (elsevier.com)
  • The GluN2B protein is one component (subunit) of a subset of specialized protein structures called NMDA receptors. (medlineplus.gov)
  • There are several types of NMDA receptors, made up of different combinations of proteins. (medlineplus.gov)
  • NMDA receptors are glutamate-gated ion channels. (medlineplus.gov)
  • NMDA receptors are involved in normal brain development, changes in the brain in response to experience (synaptic plasticity), learning, and memory. (medlineplus.gov)
  • A shortage of this protein may reduce the number of functional NMDA receptors, which would reduce receptor activity in cells. (medlineplus.gov)
  • some mutations reduce NMDA receptor signaling while others increase it. (medlineplus.gov)
  • Researchers are unsure how abnormal activity of NMDA receptors prevents normal growth and development of the brain or why too much or too little activity lead to similar neurological problems in people with GRIN2B -related neurodevelopmental disorder. (medlineplus.gov)
  • Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties. (medlineplus.gov)
  • A key recent development was the discovery of antibodies to NMDA receptors in some cases of encephalitis, characterized by cognitive changes, memory loss, seizures, and sometimes long-term morbidity or mortality. (ohsu.edu)
  • Here we describe a unique de novo autoimmune mouse model of anti-NMDA receptor encephalitis. (ohsu.edu)
  • Active immunization of immune competent mice with conformationally-stabilized, native-like NMDA receptors induced a fulminant encephalitis with behavioral and pathologic characteristics similar to those observed in the human disorder. (ohsu.edu)
  • Conantokin G, exclusive to piscivore cones, subdues prey by antagonizing the NMDA receptor, causing a sleeplike state. (medscape.com)
  • A series of short chain alkanols were studied for their effects on N-methyl-D-aspartate (NMDA)-evoked release [3H]norepinephrine (NE) from slices of cortex of the rat. (nih.gov)
  • The alkanols did not significantly depress the release of [3H]NE stimulated by 25 mM KCl, in the presence of 300 microM 2-amino-5-phosphonopentanoic acid (AP-5), suggesting that the alkanols have a selective effect at the NMDA receptor, as opposed to altering the release of neurotransmitter at the nerve terminal. (nih.gov)
  • It is concluded that the inhibitory effect of ethanol and related short chain alkanols on NMDA-stimulated release of [3H]NE involves an interaction with a lipophilic target, at or near the NMDA receptor-ionophore complex. (nih.gov)
  • Whereas excessive activation of the NMDA receptor may contribute to ischemic neuronal injury, physiologic activation may promote neuronal survival under certain conditions. (elsevier.com)
  • First characterized in 2007, anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder with the production of antibodies against the NMDA-type glutamate receptor. (journalmc.org)
  • We describe the anesthetic management of a patient with anti-NMDA receptor encephalitis who required anesthetic care during radiological imaging. (journalmc.org)
  • aminobutyric acid receptor type A (GABAA), the gaseous anesthetics nitrous oxide and xenon are reported to have little effect on GABAA receptors but inhibit N-methyl-d-aspartate (NMDA) receptors. (semanticscholar.org)
  • The discriminative stimulus effects of sub-anesthetic concentrations of isoflurane vapor appear to be mediated by both positive allosteric modulation of GABAA receptors as well as antagonism of NMDA receptors. (semanticscholar.org)
  • Previous studies revealed that antibodies reactive with NMDA (N-methyl-D-aspartate) receptor NR2 (anti-NR2) are elevated in cerebrospinal fluid (CSF) of patients with diffuse psychiatric/neuropsychological syndromes (diffuse NPSLE), which is usually more recalcitrant than neurologic syndromes of NPSLE (focal NPSLE). (altmetric.com)
  • Consistent with a prior report indicating that N -methyl- d -aspartate (NMDA) receptor (NMDAR) activation can promote steroid production, we observed that d -2-amino-5-phosphonovalerate (APV), a competitive NMDAR antagonist, blocked the effects of 60 m m ethanol on staining. (jneurosci.org)
  • It is believed that certain opioids and their metabolites agonize the N -methyl-D-aspartate (NMDA) receptor. (uspharmacist.com)
  • Activation of the NMDA receptor causes an influx of calcium that greatly enhances the excitability of the neuron. (uspharmacist.com)
  • When the NMDA receptor and corresponding neurons are more active, they can more readily transmit painful impulses initiated by circulating substance P or other noxious stimuli. (uspharmacist.com)
  • Supporting this theory of pronociception modulated by NMDA receptor activation are studies showing relief of OIH after administration of NMDA receptor antagonists. (uspharmacist.com)
  • These antagonists noncompetitively bind to the phencyclidine site on the NMDA channel and block the influx of calcium that would occur when the receptor binds glutamate or another agonist. (uspharmacist.com)
  • 10 Animal and human studies have demonstrated that subjects with OIH who were administered ketamine, an NMDA receptor antagonist, scored better during controlled pain-stimulus testing. (uspharmacist.com)
  • 5 Other NMDA receptor antagonists, such as dextromethorphan, have demonstrated some evidence of relieving hyperalgesic states through inhibition at the NMDA receptor. (uspharmacist.com)
  • The human GCOM1 complex gene interacts with the NMDA receptor and internexin-alpha. (nih.gov)
  • Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist 11 . (nature.com)
  • One theory is that Alzheimer's disease may be caused, in part, by overactivation of N-methyl-D-aspartate (NMDA) receptors by the brain transmitter glutamate, which may add to the destruction of nerve cells. (worstpills.org)
  • Memantine is thought to work by blocking the NMDA receptors from binding to glutamate, thereby preventing cell death. (worstpills.org)
  • Herpesviral encephalitis can serve as a trigger of anti-NMDA receptor encephalitis . (wikipedia.org)
  • NMDA receptors (NMDARs) mediate ischemic brain damage, in part through interactions of the PDZ ligand of NR2 subunits with the PDZ domain proteins PSD-95 and neuronal nitric oxide synthase located within the NMDAR signaling complex. (hw.ac.uk)
  • 1. Magnesium inhibits the NMDA receptors. (naturalnews.com)
  • NMDA receptors, which is short for N-methyl-D-aspartate, are crucial to the central nervous system. (naturalnews.com)
  • Magnesium helps manage these NMDA receptors , thus resulting in a better flow of thoughts and ideas. (naturalnews.com)
  • Furthermore, we discuss novel pharmacologic approaches, including the N-methyl-d-aspartate (NMDA) receptor ketamine and neuropeptide Y (NPY), as exciting new prospects for not only the treatment of PTSD but as new targets to enhance resilience. (cdc.gov)
  • The most commonly studied neuroprotective agents for acute stroke block the N -methyl-D-aspartate (NMDA) receptor. (medscape.com)
  • [ 6 ] A trial of another NMDA receptor antagonist, aptiganel HCl (Cerestat), was terminated because of concerns regarding benefit-to-risk ratios. (medscape.com)
  • 5. The role of N-methyl-D-aspartate (NMDA) receptors in generating paroxysmal events was evaluated by application of 20 μM 2-amino- 5-phosphonovaleric acid, a specific blocker of this glutamate receptor type. (haifa.ac.il)
  • Blockage of NMDA receptors cut short the paroxysmal field potentials but did not prevent their generation. (haifa.ac.il)
  • Although activation of NMDA receptors does apparently contribute to the abnormal responsiveness, they are not essential for its existence in this kindling model. (haifa.ac.il)
  • Los receptores NMDA tienen un sitio de unión alostérico para la glicina que debe estar ocupado para que el canal se abra de manera eficiente y un sitio dentro del propio canal al cual se unen los iones magnesio en una forma que depende del voltaje. (bvsalud.org)
  • 55 years on we're still finding out how it works, but one mode of action is as an NMDA receptor antagonist. (blogspot.com)
  • NMDA is N-Methyl-D-aspartate and a wholly artificial analogue of glutamate which is a natural neurotransmitter . (blogspot.com)
  • Esketamine and its parent compound ketamine work via the NMDA (N-methyl-D-aspartate) receptor in nerve cells. (psychedelicreview.com)
  • Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats. (cocites.com)
  • Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. (riajournal.com)
  • Here, we review the data that leptin influences hippocampal synaptic plasticity via enhancing NMDA (N-methyl-D-aspartate) receptor function. (ucc.ie)
  • We also provide evidence that rapid trafficking of NMDA receptors to the plasma membrane may underlie the effects of leptin on excitatory synaptic strength. (ucc.ie)
  • This treatment combination works by inhibiting N-Methyl-D-aspartate (NMDA) receptors, which increases the intracellular levels of glutamate, an excitatory neurotransmitter found throughout the central nervous system (CNS). (headinghealth.com)
  • In this review we look back at the progress made toward understanding the physiological and pathological role of NMDA receptor channels in mechanobiology of the nervous system and consider these findings in like of their potential functional implications for memory formation. (edu.au)
  • 5,6 Encephalitis associated with anti- N -methyl- d Antibodies to the -aspartate (NMDA) receptor can lead to a neuropsychiatric presentation that often includes catatonic withdrawal and is associated with viral illnesses. (setup-mcafee.com)
  • 7 The link between encephalitis associated with anti-NMDA receptor antibodies and SARS-CoV-2 has not yet been established, but a potential link has been suggested. (setup-mcafee.com)
  • To determine the immune mechanisms by which stress promotes the development of HSE, we examined the role of the glucocorticoid receptor (GR) and the N-methyl-d-aspartate (NMDA) receptor in the development of HSE. (umn.edu)
  • Our findings demonstrate that blockade of either the GR or the NMDA receptor enhances survival following HSV-1 infection in stressed mice to levels similar to non-stressed mice. (umn.edu)
  • Subsequent studies determined the effect of GR and NMDA receptor blockade on immune function by specifically examining both microglia and CD8 + T cell activation. (umn.edu)
  • Stress inhibited the expression of MHC class I by microglia and other brain-derived antigen presenting cells (CD45 hi ) independent of either the glucocorticoid receptor or the NMDA receptor, suggesting that stress-induced suppression of MHC class I expression in the brain does not affect survival during HSE. (umn.edu)
  • Blockade of the NMDA receptor, however, diminished HSV-1-induced increases in class I expression by CD45 hi cells, suggesting that blockade of the NMDA receptor may limit CNS inflammation. (umn.edu)
  • These findings indicate that stress-induced hypocellularity is mediated by the GR while NMDA receptor activation is responsible for enhancing CNS inflammation. (umn.edu)
  • The combined effects of GR-mediated hypocellularity of the SCLN and NMDA receptor-mediated CNS inflammation during stress promote the development of HSE. (umn.edu)
  • This NO 'tone' was sensitive to NOS substrate manipulation (200 μM l-arginine, 2 mM N G -nitro-l-arginine methyl ester) and Mg 2+ modulation of N-methyl-D-aspartate (NMDA) receptor conductance. (princeton.edu)
  • A drug called "memantine" which blocks the main GLU-excitotoxicity site in neurons - the NMDA GLU receptor (more on this later) - has been used clinically in Germany with significant success in treating Alzheimer's disease since 1991. (antiaging-nutrition.com)
  • 12). Memantine's NMDA GLU-receptor blocking action has also shown promise in Parkinson's disease, diabetic neuropathic pain, glaucoma, HIV dementia, alcohol dementia, and vascular (stroke or arteriosclerosis - caused dementia (12). (antiaging-nutrition.com)
  • Experimental NMDA - GLU receptor blockers such as MK-801 (dizocilpine) have also demonstrated the ability to reduce or eliminate brain damage from acute conditions such as stroke, ischaemia/hypoxia/anoxia, severe hypoglycaemia, spinal cord injury and head trauma (1-3). (antiaging-nutrition.com)
  • DeSena AD, Greenberg BM, Graves D (2014) Three Phenotypes of Anti-N-Methyl-d-Aspartate Receptor Antibody Encephalitis in Children: Prevalence of Symptoms and Prognosis. (icnapedia.org)
  • Since NMDAR and dopamine D1 receptors (D1R) form membrane signaling complexes, we investigated whether NMDAR-Ab purified from patients with NMDAR-encephalitis or schizophrenia impaired D1R surface dynamics. (pasteur.fr)
  • Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a common type of autoimmune encephalitis. (biomedcentral.com)
  • Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor. (bb-c.fr)
  • Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a neuropsychiatric disease characterized by an antibody-mediated autoimmune response against NMDAR. (bb-c.fr)
  • Anti- N -methyl D-aspartate receptor (NMDAR) encephalitis is a severe neuropsychiatric disorder that associates with prominent memory and behavioural deficits. (dxiled.com)
  • Assignment of an ionotropic glutamate receptor-like gene (GRINL1A) to human chromosome 15q22.1 by in situ hybridization. (nih.gov)
  • Low function of the N-methyl-D-Aspartate receptor (NMDAR) subtype glutamate receptor in the brain plays an important role in the pathophysiology of schizophrenia. (syneurxtrials.com)
  • In mammals, D-serine binds to an ion channel found in neurons called the N-methyl-D-aspartate type glutamate receptor (NMDAR) to regulate the transmission of messages in the brain. (lab-worldwide.com)
  • Patients' antibodies react with the N-terminal domain of the GluN1 (previously known as NR1) subunit of NMDAR causing in cultured neurons a selective and reversible internalization of cell-surface receptors. (dxiled.com)
  • Many structures and processes are involved in the development of a seizure, including neurons, ion channels, receptors, glia, and inhibitory and excitatory synapses. (medscape.com)
  • Previous studies have shown that autoantibodies targeting cell surface proteins, such as the anti- N -methyl- d -aspartate receptor (anti-NMDAR), can directly disrupt the normal function of affected neurons ( 4 , 5 ). (snmjournals.org)
  • Excitotoxins are biochemical substances (usually amino acids, amino acid analogs, or amino acid derivatives) that can react with specialized neuronal receptors - GLU receptors - in the brain or spinal cord in such a way as to cause injury or death to a wide variety of neurons (1-3, 8-10). (antiaging-nutrition.com)
  • Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. (ox.ac.uk)
  • N-methyl-D-aspartate receptors (NMDAR) are ionotropic glutamate receptors which can be blocked by Mg2+ in a voltage-dependent manner and are highly permeable to Ca2+, hence they represent a medically relevant target for neurodegenerative disorders caused by excitotoxicity. (nottingham.ac.uk)
  • A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. (childrensmercy.org)
  • An increase in post-synaptic Ca2+ conductance through activation of the ionotropic N-methyl-D-aspartate receptor (NMDAR) and concomitant structural changes are essential for the initiation of long-term potentiation (LTP) and memory formation. (edu.au)
  • This effect was not related to the size of the macroscopic currents, the quantity or ratio of injected receptor subunit RNAs, or a voltage-dependent block by spermine. (unboundmedicine.com)
  • The 5'-untranslated region of the N-methyl-D-aspartate receptor NR2A subunit controls efficiency of translation. (duke.edu)
  • GRINL1A colocalizes with N-methyl D-aspartate receptor NR1 subunit and reduces N-methyl D-aspartate toxicity. (nih.gov)
  • Tissue specific control regions of the N-methyl-D-aspartate receptor subunit NR2C promotorsubunit NR2C promotor. (mpg.de)
  • Acute blockade of dopamine D 2 receptors by the typical antipsychotic drug haloperidol leads to alterations in neuronal gene expression and behavior. (elsevier.com)
  • Many of these agents modulate neuronal receptors to reduce release of excitatory neurotransmitters, which contribute to early neuronal injury. (medscape.com)
  • La dependencia positiva del voltaje de la conductancia del canal y la elevada permeabilidad del canal conductor a los iones calcio (así como a los cationes monovalentes) son importantes en la excitotoxicidad y en la plasticidad neuronal. (bvsalud.org)
  • We name neuronal receptors after the drug which was first shown to affect them. (blogspot.com)
  • Ischemia leads to excessive activation of excitatory amino acid receptors, accumulation of intracellular calcium, and release of other toxic products that cause cellular injury. (medscape.com)
  • Chartoff, EH, Ward, RP & Dorsa, DM 1999, ' Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy ', Journal of Pharmacology and Experimental Therapeutics , vol. 291, no. 2, pp. 531-537. (elsevier.com)
  • Glutamate is the primary endogenous agonist of the NDMA receptor. (uspharmacist.com)
  • Acupuncture also suppresses N -methyl-d-aspartate receptors (NMDAR) by inducing endogenous opioids in the intrarostral anterior cingulate cortex of the brain, which contributes to the inhibition of the affective dimension of pain [ 2 ]. (biomedcentral.com)
  • These receptors are essential in human beings physiologically, taking part in the rules of all of our physiological activities such as for example neurotransmission, enzyme launch, inflammation or chemotaxis, aswell as our feeling of vision, taste and smell, by sensing endogenous or environmental stimuli through binding suitable ligands and AZD-3965 IC50 transducing related sign into cells typically through combined heterotrimeric G proteins. (mdm2-inhibitors.com)
  • When enough receptors are simultaneously activated by NTs, the neuron will either "fire" an electric current all over its surface membrane, if the transmitter/receptors are excitatory, or else the neuron will be inhibited from electrically discharging, if the NT/receptors are inhibitory. (antiaging-nutrition.com)
  • A "motor cabal" causes paralysis by blocking neuromuscular transmission through inhibition of presynaptic voltage-gated calcium channels, postsynaptic nicotinic acetylcholine receptors, acetylcholine release, or skeletal muscle voltage-gated sodium channels. (medscape.com)
  • Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. (aspetjournals.org)
  • Results suggest that inhibition of the (&agr;7)5 nACh receptor by N2O and Xe may play a role in their anesthetic effects. (semanticscholar.org)
  • Both halothane and isoflurane enhanced 5-HT3 receptor function in a concentration-dependent manner, which is consistent with previous studies and suggests the inhibitory mechanism of sevoflURane might be different from those of N2O and Xe. (semanticscholar.org)
  • It binds specifically to GABA A receptors to enhance their inhibitory effects. (medscape.com)
  • Circulating autoantibodies directed against extracellular domains of the glutamatergic N-methyl-D-aspartate receptors (NMDAR-Ab) elicit psychotic symptoms in humans and behavioral deficits in animal models. (pasteur.fr)
  • The study will investigate the efficacy of the N-methyl-D-aspartate receptor antagonist ketamine as a first line agent in refractory status epilepticus versus traditional general anesthetic agents used for burst suppression that target the gamma-aminobutyric acid adrenergic receptors. (clinicaltrials.gov)
  • Ketamine, an intravenous anesthetic agent which is a non-competitive antagonist of N-methyl-D-aspartate receptors can block the flow of Ca and Na and by combining with phencyclidine binding sites inside the ion channel of N-methyl-D-aspartate receptors, reduce the epileptiform burst discharges and after potential. (clinicaltrials.gov)
  • First, the induction and expression of the rhythms were not blocked by the N-methyl-d-aspartate receptor antagonist d-2-amino-5-phosphonovaleric acid, indicating that a long-term potentiation effect between pyramidal cells was not involved. (escholarship.org)
  • Technically, the anesthetic ketamine is not a hallucinogen because it is an antagonist of the serotonin 5-HT 2A receptor. (psychedelicreview.com)
  • The intensity of the paroxysmal response was greatly enhanced by application of γ- aminobutyric acid-A (GABAa) receptor blockers to the bath. (haifa.ac.il)
  • Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics. (pasteur.fr)
  • Muscarinic acetylcholine receptors, vital components of the parasympathetic nervous system, were discovered by injecting muscarine which is produced by certain mushrooms . (blogspot.com)
  • When brain chemicals called glutamate and glycine attach to the receptor, a channel opens, allowing positively charged particles (cations) to flow through. (medlineplus.gov)
  • This paper is about a very different glycine receptor, the homomeric alpha2 receptor. (ucl.ac.uk)
  • In this paper we find, for both glycine and nicotinic receptors, that opening and shutting of the channel is very much the same for partial and full agonists. (ucl.ac.uk)
  • Andrew J.R. Plested, Paul J Groot-Kormelink, David Colquhoun, and Lucia G Sivilotti (2007) Single channel study of the spasmodic mutation {alpha}1A52S in recombinant rat glycine receptors. (ucl.ac.uk)
  • A study of the spasmodic mutation in the glycine receptor. (ucl.ac.uk)
  • When interpreted in terms of the 'flip' mechanism , the results suggest that the impairment of the receptor function results largely from a large reduction in the affinity of glycine for the flipped conformation, i.e. a shut conformation of the receptor that can be adopted once the ligand is bound, but precedes the opening of the channel. (ucl.ac.uk)
  • Methadone is a synthetic opioid and full agonist at the μ-opioid receptor and induces other opioid receptors. (statpearls.com)
  • These potent peptides, which fold into small, highly structured frameworks, largely target ion channels, either voltage- or ligand-gated receptors and transporters in excitable cells. (medscape.com)
  • Predicated on series homology, ligand framework or receptor function, GPCRs are categorized into several hundred subfamilies. (mdm2-inhibitors.com)
  • N-methyl-D-aspartate receptor (NMDAR) hypofunction is hypothesised to underlie psychosis but this has not been tested early in illness. (ox.ac.uk)
  • Shank2 −/− mice, known to display N-methyl-D-aspartate receptor (NMDAR) hypofunction and autistic-like behaviors at postweaning stages after postnatal day 21 (P21), show the opposite synaptic phenotype-NMDAR hyperfunction-at an earlier preweaning stage (∼P14). (elsevier.com)
  • Therefore, targeting the N-methyl-D-aspartate receptors with ketamine may provide a novel approach to control refractory seizures. (clinicaltrials.gov)
  • Moreover, by blocking glutamate mediated N-methyl-D-aspartate receptor induced neurotoxicity, ketamine may render neuroprotection. (clinicaltrials.gov)
  • Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. (cocites.com)
  • Opioid receptors for example: we don't make opium or its derivatives in our brains but we do have receptors that are responsive to these alien chemicals. (blogspot.com)
  • The μ-opioid receptors, located in the CNS (e.g., brainstem, locus coeruleus, periaqueductal gray matter) and parts of the gastrointestinal tract, act to modulate various neurochemical activities involved in analgesia, euphoria, and sedation. (statpearls.com)
  • Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. (cdc.gov)
  • An entire subset of antibody-positive patients, anti- N -methyl- d -aspartate receptor (5 patients), had normal MRI results and abnormal 18 F-FDG PET/CT findings whereas the other subsets demonstrated a greater heterogeneity. (snmjournals.org)
  • Remigijus Lape, Paraskevi Krashia, David Colquhoun and Lucia G. Sivilotti (2009)) Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors. (ucl.ac.uk)
  • In the hippocampus, leptin is a potential cognitive enhancer as genetically obese rodents with dysfunctional leptin receptors display impairments in hippocampal synaptic plasticity. (ucc.ie)
  • Introduction G-protein combined receptors (GPCRs), known as seven-transmembrane (7TM) site receptors also, although diverse functionally, constitute the biggest integral membrane proteins family members in the human being genome [1]C[3]. (mdm2-inhibitors.com)
  • AMPA receptors, when assayed in heterologous expression systems, showed a sensitivity to inhalational anesthetics that was minimal when glutamate was applied rapidly at high concentrations, which concludes that AMPA receptors are unlikely to play a major role in the production of the anesthetic state by inhalational agents. (semanticscholar.org)
  • This is attributed to decrease in activity of gamma-aminobutyric acid receptors along with reciprocal up regulation of N-Methyl-D-aspartate receptors. (clinicaltrials.gov)
  • Glutamate activation of N-methyl-D-aspartate receptors promotes calcium influx and excitotoxicity. (clinicaltrials.gov)
  • The GABA receptors are the neurotransmitters responsible for calming nerve activity. (naturalnews.com)
  • These activate insulin receptors in prey, mimicking the effects of insulin and causing prey "insulin shock" with disorientation. (medscape.com)
  • For the present study, a terpenoid constituent from G. biloba , bilobalide, was screened for protective effects on the ischaemic heart and the involvement of the PAFR [PAF (platelet-activating factor) receptor] and the enzyme that degrades PAF, PAF-AH (PAF acetylhydrolase) during hypoxia. (portlandpress.com)
  • Our results indicate that PAF and its receptor may be involved in the cellular response of cardiomyocytes to hypoxia and that bilobalide may interact with this receptor to exert its cardioprotective effects. (portlandpress.com)